Other respiratory diseases principally affecting the interstitium

J10_INTERSTITIUM

pulmonary edema: Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J80-J84 Cause of death: ICD-10 — J80-J84 2 out of 7 registries used, show all original rules.	8892
4. Check minimum number of events None	8892
5. Include endpoints J10_ARDS J10_PULMOEDEMA J10_PULMEOS J10_OTHERINSTPULM	9264
6. Filter based on genotype QC (FinnGen only)	8129

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	J10_INTERSTITIUM
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	J10_ARDS\|J10_PULMOEDEMA\|J10_PULMEOS\|J10_OTHERINSTPULM
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J8[0-4]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J8[0-4]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other respiratory diseases principally affecting the interstitium based on the number of shared cases.

Similar with more cases:

Diseases of the respiratory system

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8129	3272	4857
Unadjusted period prevalence (%)	1.80	1.16	2.23
Median age at first event (years)	69.94	67.45	71.61

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8381: Matched controls
83806

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

313.2

2404

11154

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.4

308.2

3838

22143

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

4032.0

307.7

395

R06.0

ICD-10 Finland

Dyspnoea

2.9

307.7

3628

17395

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

5.5

307.7

1134

2336

J96.1

ICD-10 Finland

Chronic respiratory failure

7.3

307.7

653

958

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

16384.0

307.7

1983

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.4

307.7

5865

34346

XG410

NOMESCO Finland

Flow-volume spirometry

7.3

307.7

998

1518

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

14.2

307.7

1142

924

L04AX05

ATC

pirfenidone; oral

+∞

307.7

420

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

26.3

307.7

292

115

L04AA06

ATC

mycophenolic acid; systemic

13.4

307.7

587

469

L01EX09

ATC

nintedanib; oral

3401.0

307.7

337

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.4

307.7

1035

2621

GD1AD

NOMESCO Finland

Thorax CT examination

6.2

307.7

1602

3100

TGC00

NOMESCO Finland

Bronchial lavation

27.3

307.7

1657

751

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.3

307.7

936

2356

J80

ICD-10 Finland

Adult respiratory distress syndrome

1254.7

307.7

474

R03AC02

ATC

salbutamol; inhalant

2.4

307.7

5067

32443

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

21.5

307.7

386

188

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.1

307.7

1719

4973

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

59.7

307.7

255

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

7242.1

307.7

3274

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.7

307.7

1235

3700

H02AB06

ATC

prednisolone; systemic

4.4

307.7

6025

30985

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

20.5

307.7

2726

1925

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

6065.1

307.7

3715

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.3

307.7

1566

5458

L04AX01

ATC

azathioprine; systemic

6.9

307.7

823

1308

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.9

307.7

4505

19079

284

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

307.7

646

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

8.5

307.7

776

997

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

6.4

307.7

2796

6050

356

Kela drug reimbursment

Nintedanib and pirfenidone

6860.4

307.7

645

UGC12

NOMESCO Finland

Flexible bronchoscopy

8.8

307.7

2601

4095

J81

ICD-10 Finland

Pulmonary oedema

738.8

307.7

741

J01MA14

ATC

moxifloxacin; systemic

3.2

287.3

1284

4434

Z94.2

ICD-10 Finland

Lung transplant status

66.2

284.8

156

P01BA02

ATC

hydroxychloroquine; oral

3.5

270.0

1044

3290

C03CA01

ATC

furosemide; systemic

2.2

257.1

4077

25403

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

3.8

238.7

780

2191

GX1K5

NOMESCO Finland

Diffusion capacity

15.0

234.2

208

142

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.3

230.7

621

1514

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.6

227.2

809

2406

R03BB04

ATC

tiotropium bromide; inhalant

2.7

226.2

1484

6266

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

5.3

225.3

470

928

GX1D5

NOMESCO Finland

Flow volume spirometry

28.6

222.4

149

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

18.4

221.5

177

L01XE31

ATC

[U] nintedanib

+∞

216.6

207

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

1895.0

201.7

195

I50.9

ICD-10 Finland

Heart failure, unspecified

2.2

191.8

2164

11527

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

9.6

184.5

218

232

A02BC02

ATC

pantoprazole; systemic

2.1

177.8

6147

47995

M05BA04

ATC

alendronic acid; oral

2.6

173.5

1130

4712

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

7.0

173.4

269

397

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

8.6

171.9

222

265

J47

ICD-10 Finland

Bronchiectasis

5.2

166.9

356

715

127

Kela drug reimbursment

Transplant complication

7.0

166.1

256

375

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.3

164.6

445

1084

48499

ICD-8 Finland

Acute interstitial pneumonia

+∞

164.1

157

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

163.3

1440

6884

J01MA12

ATC

levofloxacin; systemic

2.1

157.8

2074

11583

L04AX03

ATC

methotrexate; systemic

2.6

153.5

977

4015

WX892

NOMESCO Finland

Monitored bed care

2.6

153.1

968

3965

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

152.8

1892

10322

R02

ICPC

Shortness of breath/dyspnoea

2.2

150.9

1529

7718

R03AK08

ATC

formoterol and beclometasone; inhalant

3.5

149.4

545

1636

J43.9

ICD-10 Finland

Emphysema, unspecified

5.0

145.9

320

658

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

144.2

1852

10214

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

143.1

2552

15737

R05

ICD-10 Finland

Cough

2.0

142.6

2019

11521

L04AA13

ATC

[U] leflunomide

4.7

141.8

333

725

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.9

139.3

723

2670

I50.0

ICD-10 Finland

Congestive heart failure

2.3

137.6

1169

5470

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

9.4

137.6

165

179

WX721

NOMESCO Finland

Oxygen concentrator therapy

17.8

137.1

111

J45.1

ICD-10 Finland

Nonallergic asthma

2.7

135.2

810

3222

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

233.8

134.4

138

GDG10

NOMESCO Finland

Bilateral transplantation of lung

159.3

133.7

141

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

133.0

2070

12158

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

130.9

2206

13290

L04AD01

ATC

ciclosporin; systemic

5.5

129.6

255

476

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

+∞

129.5

124

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.4

125.7

477

1466

A07EC01

ATC

sulfasalazine; oral, rectal

2.6

124.6

801

3294

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.9

121.2

370

983

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

121.1

1338

6934

XX4BW, ,

NOMESCO Finland

30.7

120.6

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

7.3

120.4

178

249

R03BA08

ATC

ciclesonide; inhalant

2.5

119.7

825

3504

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

117.8

2557

16553

L01BA01

ATC

methotrexate; systemic

3.4

116.6

433

1312

R50.9

ICD-10 Finland

Fever, unspecified

2.0

114.8

1509

8316

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.7

114.3

655

2541

L04AD02

ATC

tacrolimus; systemic

7.8

112.0

155

201

R04.2

ICD-10 Finland

Haemoptysis

3.0

111.2

516

1786

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

110.3

1414

7713

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.2

109.6

303

749

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.8

108.8

250

534

ZX108

NOMESCO Finland

Inhalation

7.9

108.7

149

191

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

108.1

1850

11099

R4110

NOMESCO Finland

Physiotherapy

1.7

108.1

2514

16520

WW200

NOMESCO Finland

Immunization

3.8

104.8

328

886

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

104.6

4028

30166

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

54.0

103.5

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

4.2

103.1

281

687

R81

ICPC

Pneumonia

3.0

102.5

484

1691

J96.0

ICD-10 Finland

Acute respiratory failure

4.6

101.2

242

534

J67.9

ICD-10 Finland

Hypersensitivity pneumonitis due to unspecified organic dust

24.7

100.6

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

100.1

2759

18904

ZX120

NOMESCO Finland

Intravenous

2.2

98.6

957

4693

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.8

96.9

298

795

R99

ICPC

Respiratory disease other

4.1

95.4

265

657

WX726

NOMESCO Finland

High-flow oxygen therapy

18.9

95.2

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.5

94.6

633

2643

J01FA06

ATC

roxithromycin; oral

1.6

94.4

3220

23208

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

94.0

850

4048

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

93.2

1309

7330

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

6.4

93.2

156

249

J01AA02

ATC

doxycycline; systemic

1.7

93.1

6346

54077

H02AB07

ATC

prednisone; oral

1.9

92.9

1313

7367

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

91.9

665

2877

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

91.8

715

3196

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

7.6

89.3

127

170

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

88.6

1536

9186

XG466

NOMESCO Finland

Sleep oxymetry

3.2

88.3

373

1221

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

87.7

2657

18511

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

87.0

1969

12708

D86.0

ICD-10 Finland

Sarcoidosis of lung

5.4

84.6

168

316

L88

ICPC

Rheumatoid/seropositive arthritis

2.9

84.4

424

1530

R28

ICPC

Limited function/disability (R)

4.4

83.2

211

488

C07AB07

ATC

bisoprolol; oral

1.6

83.0

4684

37557

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

3.1

82.3

357

1186

GX2C5

NOMESCO Finland

Short-lasting oximetry

8.3

81.1

107

131

WX722

NOMESCO Finland

PEEP

2.5

79.4

511

2091

Z3226

NOMESCO Finland

Physiotherapist

1.7

78.8

1589

9895

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.4

78.5

287

859

ZXE00

NOMESCO Finland

One hour or less

1.6

77.7

3112

23004

R05

ICPC

Cough

1.7

77.4

1984

13173

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.8

77.0

407

1508

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

75.9

1256

7373

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.5

74.5

145

268

R03BA02

ATC

budesonide; inhalant

1.8

74.2

1423

8720

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

74.0

2071

14034

GDA10

NOMESCO Finland

Biopsy of lung

13.8

72.4

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.9

71.8

215

563

WX872

NOMESCO Finland

Intensive care

2.3

71.3

575

2601

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

70.8

1163

6800

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.6

70.6

240

685

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

70.6

1550

9849

L04AA01

ATC

[U] ciclosporin

4.5

69.8

171

385

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

69.5

632

3004

N02AX02

ATC

tramadol; systemic, rectal

1.5

69.3

3629

28208

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

19.7

68.6

J43.8

ICD-10 Finland

Other emphysema

9.1

68.0

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

12.0

67.7

N02AA01

ATC

morphine; systemic, rectal

3.1

66.8

286

943

JN4AD

NOMESCO Finland

Body CT examination

1.8

65.9

1172

7008

Z2221

NOMESCO Finland

Medical doctor

1.6

65.7

2148

15035

F1246, ,

NOMESCO Finland

15.1

64.8

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

64.5

527

2396

L04AA24

ATC

abatacept; parenteral

9.5

64.2

XX2RW, ,

NOMESCO Finland

4.1

64.1

180

450

Z3231

NOMESCO Finland

Registered nurse

1.5

63.9

2314

16556

J01CA04

ATC

amoxicillin; systemic

1.5

63.7

6193

54185

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.2

63.4

561

2635

XX9XE

NOMESCO Finland

Other ultrasound examination

5.9

63.1

113

193

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

62.8

810

4374

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

22.0

62.3

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

62.2

911

5126

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

19.0

62.2

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

6.4

62.0

102

160

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.2

62.0

587

2832

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.7

61.5

199

550

A02BC01

ATC

omeprazole; systemic

1.5

61.4

2352

17007

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

6.2

61.2

105

172

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.2

61.0

248

793

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.3

60.9

239

748

A03

ICPC

Fever

1.8

60.6

1126

6804

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

60.2

655

3329

120

Kela drug reimbursment

Hypogammaglobulinaemia

17.6

60.1

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

60.0

1501

9823

R03DC03

ATC

montelukast; oral

1.7

59.7

1166

7144

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

59.6

744

3969

F2680, ,

NOMESCO Finland

13.4

59.6

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

9.3

59.2

J01FF01

ATC

clindamycin; systemic

1.5

58.6

2124

15148

A07AA02

ATC

nystatin; oral

2.1

58.3

572

2796

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

12.8

58.0

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

57.9

2918

22269

R03BA05

ATC

fluticasone; inhalant

1.7

57.5

1359

8755

TK800

NOMESCO Finland

Hemodialysis

3.1

57.5

248

821

M05BA07

ATC

risedronic acid; oral

2.6

57.0

328

1269

R03BA01

ATC

beclometasone; inhalant

1.7

56.4

1155

7163

J43.2

ICD-10 Finland

Centrilobular emphysema

7.7

56.4

104

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.4

56.1

202

599

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

55.7

902

5227

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

55.7

1106

6798

I50.1

ICD-10 Finland

Left ventricular failure

2.0

55.5

612

3123

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

11.5

55.1

C01DA14

ATC

isosorbide mononitrate; oral

1.6

55.0

1842

12880

L04AB01

ATC

etanercept; parenteral

4.2

54.8

146

351

H02AB04

ATC

methylprednisolone; systemic

1.7

54.7

1170

7336

J84

ICD-10 Finland

Other interstitial pulmonary diseases

541.6

54.6

J92.9

ICD-10 Finland

Pleural plaque without asbestos

3.7

54.5

173

472

D72.1

ICD-10 Finland

Eosinophilia

7.7

53.8

5AB14, ,

NOMESCO Finland

19.2

53.6

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

53.4

950

5658

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

52.9

901

5296

M34.1

ICD-10 Finland

CR(E)ST syndrome

8.2

52.9

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

19.6

52.8

M04AA01

ATC

allopurinol; systemic

1.6

52.3

1419

9438

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

52.3

431

1963

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.0

51.8

149

379

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

9.7

51.8

GX2D5

NOMESCO Finland

Sleep oximetry

6.1

51.5

147

J12.8

ICD-10 Finland

Other viral pneumonia

4.5

51.4

125

280

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.0

50.7

609

3200

AN1

Coronary angiography

1.7

50.4

1177

7540

M01CB01

ATC

sodium aurothiomalate; parenteral

3.8

50.3

156

419

WX730

NOMESCO Finland

Conventional respirator

3.3

49.5

189

582

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

6.4

49.4

130

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.6

48.6

293

1159

WX882

NOMESCO Finland

High dependency care

2.6

48.5

293

1160

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.3

48.5

371

1637

A10AC01

ATC

insulin (human); parenteral

1.9

48.5

706

3953

ZXD05

NOMESCO Finland

Urgent procedure

1.5

48.3

2358

17740

H02AB09

ATC

hydrocortisone; systemic

3.0

47.6

217

742

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.7

47.4

264

1004

M05.1

ICD-10 Finland

Rheumatoid lung disease

164.3

46.9

B01AA03

ATC

warfarin; systemic

1.5

46.7

2043

15026

L04AB04

ATC

adalimumab; parenteral

3.4

46.4

167

495

WZC30

NOMESCO Finland

Teaching

1.6

46.3

1363

9216

A02BC05

ATC

esomeprazole; systemic

1.4

46.0

3097

24643

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

3.9

45.8

135

350

J01FA10

ATC

azithromycin; systemic

1.4

45.5

3678

30170

Z57.2

ICD-10 Finland

Occupational exposure to dust

6.6

45.4

112

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

4.3

45.3

117

275

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

44.7

403

1903

G47.3

ICD-10 Finland

Sleep apnoea

1.5

44.6

1726

12371

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

44.6

3282

26471

C03DA01

ATC

spironolactone; oral

1.6

44.6

1200

7940

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.2

44.5

376

1730

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

44.2

1125

7343

M81.4

ICD-10 Finland

Drug-induced osteoporosis

5.8

44.0

139

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

3.1

43.9

188

620

Z51.5

ICD-10 Finland

Palliative care

1.7

43.8

942

5893

5183A

ICD-9 Finland

Other diseases of lung, Pulmonary eosinophilia

+∞

43.8

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

43.7

2513

19409

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

8.9

43.6

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.3

43.5

337

1495

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

43.4

1973

14589

Z2446

NOMESCO Finland

Social worker

2.0

43.4

494

2546

WZA10

NOMESCO Finland

Extensive medical or dental certificate

3.9

43.0

126

325

J45.8

ICD-10 Finland

Mixed asthma

2.5

43.0

282

1161

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

42.5

1150

7613

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

42.2

1967

14600

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

42.1

345

1567

J46

ICD-10 Finland

Status asthmaticus

2.5

42.0

261

1048

M34.0

ICD-10 Finland

Progressive systemic sclerosis

13.5

41.6

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

4.9

41.6

187

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.0

41.0

116

292

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

40.9

589

3282

J15.8

ICD-10 Finland

Other bacterial pneumonia

4.1

40.7

112

276

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

40.6

1267

8657

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

4.7

40.5

199

R03AK11

ATC

formoterol and fluticasone; inhalant

2.8

40.3

211

778

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

40.1

342

1579

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.5

40.0

221

A10AB05

ATC

insulin aspart; parenteral

1.8

39.8

666

3883

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

39.2

427

2165

E0000UV, ,

ATC

1.4

39.0

3057

24749

R06AE07

ATC

cetirizine; oral

1.4

39.0

2907

23347

M35.1

ICD-10 Finland

Other overlap syndromes

5.9

38.9

117

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

200.9

38.8

A01AB09

ATC

miconazole; local oral

1.7

38.7

686

4065

J67.0

ICD-10 Finland

Farmer lung

10.3

38.6

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.1

38.2

398

1986

JN4BD

NOMESCO Finland

Extensive body CT

1.6

38.0

918

5903

R06.2

ICD-10 Finland

Wheezing

2.1

38.0

354

1693

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

38.0

743

4525

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

37.8

2065

15728

XJC10

NOMESCO Finland

Oesophageal pH monitoring

5.5

37.7

131

XPX04

NOMESCO Finland

Angioscopy

8.1

37.5

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

37.5

549

3074

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

37.3

2762

22117

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

5.0

37.3

158

D07AC01

ATC

betamethasone; topical

1.4

36.9

2758

22111

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.7

36.8

179

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

4.2

36.7

232

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

36.7

504

2764

RS123, ,

NOMESCO Finland

12.5

36.6

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

6.6

36.5

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.3

36.3

138

424

N03AX16

ATC

[U] pregabalin

1.4

36.2

1737

12909

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

36.1

371

1842

SPAT1262

SPAT

Handing over of treatment supplies

1.5

35.7

1497

10841

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

98.0

35.7

J20

ICD-10 Finland

Acute bronchitis

1.7

35.7

739

4567

R03DA04

ATC

theophylline; systemic, rectal

1.8

35.6

529

2974

J01DB01

ATC

cefalexin; oral

1.4

34.7

6286

57335

L01AA01

ATC

cyclophosphamide; systemic

5.3

34.7

134

1CX01, ,

NOMESCO Finland

10.9

34.6

A02BC03

ATC

lansoprazole; oral

1.4

34.3

2242

17548

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

34.3

370

1870

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

34.0

406

2126

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

33.5

974

6531

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

33.5

489

2734

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

3.2

33.4

132

416

51920

ICD-8 Finland

Other diseases of respiratory system, Infiltratio pulmonis eosinophilica

+∞

33.3

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4.6

33.3

170

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

33.2

1071

7344

N18.8

ICD-10 Finland

Other chronic renal failure

2.2

32.8

268

1216

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

32.7

235

1009

J94.1

ICD-10 Finland

Fibrothorax

35.2

32.7

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

6.5

32.7

R4190

NOMESCO Finland

Nutritional therapy

2.2

32.7

281

1302

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.5

32.6

214

882

WX740

NOMESCO Finland

Nitrogen oxide therapy

11.8

32.5

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

32.2

355

1807

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.2

32.2

130

415

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

32.1

445

2447

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.0

32.1

145

494

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

32.1

2862

23442

J01FA15

ATC

telithromycin; oral

1.7

31.9

641

3925

R03AC12

ATC

salmeterol; inhalant

1.9

31.9

411

2207

R03AC13

ATC

formoterol; inhalant

1.9

31.9

411

2208

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

31.8

831

5435

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

31.7

1358

9851

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.3

31.7

237

1036

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.7

31.6

608

3680

XG460

NOMESCO Finland

Short time oxymetry

2.7

31.5

165

609

TGD00

NOMESCO Finland

Needle biopsy of lung

4.7

31.4

154

N05CF01

ATC

zopiclone; oral

1.3

31.3

2587

20936

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

31.1

617

3765

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.6

31.1

185

728

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

5.5

31.0

107

1XC02, ,

NOMESCO Finland

4.2

30.5

195

C09AA05

ATC

ramipril; oral

1.4

30.4

2288

18236

XG405

NOMESCO Finland

Education on PEF monitoring

2.9

30.4

139

477

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

30.3

2243

17832

J93.8

ICD-10 Finland

Other pneumothorax

4.7

30.3

151

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

30.3

792

5179

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

30.3

2830

23286

M33.1

ICD-10 Finland

Other dermatomyositis

11.1

30.2

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

7.7

30.1

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

30.1

1325

9656

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

9.3

30.0

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.4

29.9

209

887

ZXA10

NOMESCO Finland

Bilateral

1.4

29.9

1479

11004

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

29.8

1083

7601

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

29.7

2631

21467

J98.4

ICD-10 Finland

Other disorders of lung

7.5

29.7

H05AA02

ATC

teriparatide; parenteral

4.9

29.7

134

2AX04, ,

NOMESCO Finland

45.2

29.6

318

Kela drug reimbursment

Teriparatide

4.6

29.6

150

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

29.5

469

2688

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

10.7

29.5

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

29.5

269

1276

R29

ICPC

Respiratory symptom/complaint other

1.8

29.4

498

2909

J01FA09

ATC

clarithromycin; systemic

1.4

29.3

1980

15508

R03BB01

ATC

ipratropium bromide; inhalant

1.9

29.1

393

2142

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.3

28.8

225

1002

M33.2

ICD-10 Finland

Polymyositis

6.7

28.8

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.6

28.8

171

673

J99.0

ICD-10 Finland

Rheumatoid lung disease

80.4

28.7

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.3

28.7

223

992

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.1

28.6

117

377

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.3

28.5

224

1001

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

28.3

937

6450

I25.2

ICD-10 Finland

Old myocardial infarction

1.6

28.3

722

4691

R03AC03

ATC

terbutaline; inhalant

1.5

28.3

933

6417

J01MA02

ATC

ciprofloxacin; systemic

1.3

28.2

3172

26702

J18

ICD-10 Finland

Pneumonia, organism unspecified

3.4

28.1

102

305

J01DA01

ATC

[U] cefalexin

1.3

28.1

4519

39842

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

6.9

27.9

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

27.9

333

1744

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.2

27.9

174

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.6

27.7

611

3829

GAA31

NOMESCO Finland

Thoracoscopy

5.3

27.7

104

1240

FHL

Bronchoscopy

3.0

27.6

123

416

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

27.5

2945

24597

J02AC03

ATC

voriconazole; systemic

6.9

27.5

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

27.5

632

4004

B01AC04

ATC

clopidogrel; oral

1.4

27.4

1595

12178

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.7

27.4

234

M31.3

ICD-10 Finland

Wegener granulomatosis

5.6

27.0

WX002

NOMESCO Finland

Sedation and analgesia

1.4

26.9

1498

11351

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.4

26.8

184

775

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.8

26.6

127

N03AX12

ATC

[U] gabapentin; oral

1.4

26.5

1157

8399

J05AB11

ATC

valaciclovir; oral

1.5

26.4

997

7042

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

3.4

26.4

278

5BA08, ,

NOMESCO Finland

4.4

26.3

152

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

2.9

26.3

127

450

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

4.0

26.2

191

J98.2

ICD-10 Finland

Interstitial emphysema

10.4

26.2

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.6

26.2

148

569

SPAT1263

SPAT

Sampling

1.3

26.1

3026

25490

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

26.1

461

2723

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.1

25.9

109

357

UJF32

NOMESCO Finland

Coloscopy

1.3

25.7

2116

17012

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.9

25.6

123

434

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

25.4

401

2294

A46

ICD-10 Finland

Erysipelas

1.4

25.3

1264

9395

XA421

NOMESCO Finland

Nocturnal polygraphy

5.0

25.3

109

L04AA17

ATC

[U] adalimumab

6.3

25.2

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.0

25.2

109

363

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

25.1

301

1578

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.0

25.1

263

1316

5169X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy

+∞

25.0

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

4.1

25.0

167

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

9.7

25.0

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

24.9

2057

16536

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.2

24.8

206

942

SPAT1255

SPAT

Intravenous administration of medicine

1.6

24.8

554

3484

S97

ICPC

Chronic ulcer skin

1.6

24.7

577

3669

N02AA05

ATC

oxycodone; systemic

1.4

24.6

1651

12866

R01AD08

ATC

fluticasone; nasal

1.3

24.4

1735

13638

XQ800

NOMESCO Finland

Prick test

1.8

24.2

375

2134

XF622

NOMESCO Finland

Measurement of minute volume of heart

5.4

23.9

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

3.5

23.8

233

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

3.7

23.6

206

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

23.5

248

1245

132

Kela drug reimbursment

Sarcoidosis

3.9

23.4

171

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

23.3

1410

10804

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

7.0

23.3

Angiography of the heart and coronary arteries

1.6

23.2

634

4181

3AC01, ,

NOMESCO Finland

3.2

23.1

277

293

Kela drug reimbursment

Baricitinib

9.1

22.9

5185A

ICD-9 Finland

Other diseases of lung, Pulmonary insufficiency following trauma and surgery

+∞

22.9

5163A

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis

+∞

22.9

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

22.7

749

5141

WPA13

NOMESCO Finland

Palliative consultation

4.0

22.7

157

RK110, ,

NOMESCO Finland

3.4

22.7

245

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.3

22.7

174

771

3A006, ,

NOMESCO Finland

230.6

22.6

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

6.4

22.6

J02AC01

ATC

fluconazole; systemic

1.3

22.4

2203

18081

Z94.0

ICD-10 Finland

Kidney transplant status

3.2

22.4

277

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

22.4

631

4187

WX402

NOMESCO Finland

General anaesthesia

1.4

22.4

1451

11228

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.2

22.4

197

923

3006

Kela drug reimbursment

Baricitinib

8.3

22.2

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

3.8

22.2

173

H26.3

ICD-10 Finland

Drug-induced cataract

4.1

22.2

151

I50

ICD-10 Finland

Heart failure

1.8

22.2

328

1841

I27.0

ICD-10 Finland

Primary pulmonary hypertension

6.5

22.1

J94.8

ICD-10 Finland

Other specified pleural conditions

2.3

22.0

171

761

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.2

22.0

265

R03BB07

ATC

umeclidinium bromide; inhalant

3.2

21.9

271

L04AA37

ATC

[U] baricitinib

8.5

21.9

R24

ICPC

Haemoptysis

3.3

21.7

247

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

21.7

249

1287

WPA11

NOMESCO Finland

Developing a plan for palliative care

5.1

21.6

R01AD09

ATC

mometasone; nasal

1.3

21.5

2766

23449

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

21.5

4921

44557

J45

ICD-10 Finland

Asthma

1.5

21.5

652

4396

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

21.5

390

2322

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

21.4

1782

14287

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.7

21.4

378

2235

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.2

21.3

179

823

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.4

21.3

221

XF402

NOMESCO Finland

ECG with work load test

1.4

21.3

852

6075

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

9.0

21.2

291

Kela drug reimbursment

Tofacitinib

7.2

21.2

M05BX04

ATC

denosumab; parenteral

1.6

21.1

514

3297

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

21.1

312

1750

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

21.0

2210

18267

M10.9

ICD-10 Finland

Gout, unspecified

1.5

21.0

657

4460

L04AC07

ATC

tocilizumab; parenteral

5.5

21.0

R03AC19

ATC

olodaterol

4.2

20.8

128

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.0

20.8

232

1188

C08CA05

ATC

nifedipine; systemic

1.6

20.8

536

3486

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

20.7

1552

12256

R76.0

ICD-10 Finland

Raised antibody titre

5.7

20.7

L04AB05

ATC

certolizumab pegol; parenteral

5.7

20.7

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.6

20.6

120

469

A28

ICPC

Limited function/disability NOS

1.3

20.6

1694

13554

B01AB05

ATC

enoxaparin; parenteral

1.3

20.5

2424

20322

WX723

NOMESCO Finland

CPAP therapy

1.9

20.5

277

1513

A11CC03

ATC

alfacalcidol; systemic

2.0

20.4

207

1024

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

20.4

3240

28102

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

7.8

20.4

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

20.3

2424

20335

ZX114

NOMESCO Finland

Intramuscular

2.8

20.3

101

364

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

20.3

2114

17443

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

20.3

627

4245

R01AD12

ATC

fluticasone furoate; nasal

1.3

20.1

1671

13380

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

20.1

1026

7632

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.5

20.1

612

4131

I73.0

ICD-10 Finland

Raynaud syndrome

2.6

20.0

113

435

C10AA03

ATC

pravastatin; oral

1.5

20.0

619

4192

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

19.9

408

2508

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.0

19.9

220

1123

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

4.9

19.9

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

19.9

603

4066

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

19.8

283

1571

L01CB

ATC

Podophyllotoxin derivatives

6.1

19.8

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

19.8

654

4489

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

19.8

360

2146

B02.9

ICD-10 Finland

Zoster without complication

1.5

19.6

548

3628

R74

ICPC

Upper respiratory infection acute

1.3

19.6

1594

12719

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

3.6

19.6

184

L04AB06

ATC

golimumab; parenteral

3.8

19.6

152

J05AB01

ATC

aciclovir; systemic

1.3

19.6

1443

11360

N02BE01

ATC

paracetamol; systemic, rectal

1.3

19.5

6948

65867

C01AA05

ATC

digoxin; systemic

1.4

19.4

813

5841

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.0

19.3

276

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

19.3

406

2513

RK320, ,

NOMESCO Finland

3.0

19.3

292

D07AC13

ATC

mometasone; topical

1.3

19.3

1969

16189

6BA02, ,

NOMESCO Finland

6.3

19.2

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.6

19.2

400

2471

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

19.1

412

2566

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.6

19.1

460

2944

L04AA29

ATC

[U] tofacitinib

6.7

19.1

M05BA06

ATC

ibandronic acid; systemic

2.2

19.1

155

704

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.3

19.0

141

617

N07BA03

ATC

varenicline; oral

1.9

19.0

246

1326

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

18.9

409

2551

ZXA00

NOMESCO Finland

Right side

1.3

18.9

2027

16761

ZXA05

NOMESCO Finland

Left side

1.3

18.8

1881

15412

N18.0

ICD-10 Finland

End-stage renal disease

2.6

18.8

106

408

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

18.8

302

1738

SPAT1325

SPAT

Vaccination

1.3

18.7

2627

22411

GD1CQ

NOMESCO Finland

Lung circulation SPECT with low dose CT

6.5

18.7

R04.0

ICD-10 Finland

Epistaxis

1.5

18.7

652

4522

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

18.7

303

1749

RS221, ,

NOMESCO Finland

2.6

18.5

106

411

J32.4

ICD-10 Finland

Chronic pansinusitis

2.6

18.5

108

423

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

18.4

1209

9349

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

4.7

18.4

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.2

18.4

156

722

D07AB08

ATC

desonide; topical

1.4

18.3

720

5110

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

18.2

2148

17949

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

17.6

18.2

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

5.6

18.2

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

19.3

18.1

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

3.0

18.0

266

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.8

18.0

304

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

18.0

613

4233

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.6

18.0

424

2701

M01CB03

ATC

auranofin; oral

3.3

18.0

210

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

3.7

17.9

148

I20.09

ICD-10 Finland

Unstable angina

1.5

17.8

522

3493

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.1

17.8

247

Z94.1

ICD-10 Finland

Heart transplant status

6.9

17.8

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

17.7

1269

9933

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

2.4

17.7

118

492

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.2

17.7

155

727

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

17.6

708

5045

ED1AA

NOMESCO Finland

Mandibular X-ray examination

3.4

17.6

178

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.7

17.6

364

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.9

17.5

281

R2110

NOMESCO Finland

Giving the first information

1.6

17.5

380

2372

XF404

NOMESCO Finland

Ambulatory ECG

1.5

17.5

675

4774

J86.9

ICD-10 Finland

Pyothorax without fistula

2.8

17.5

320

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.1

17.3

156

739

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.3

17.3

131

578

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.2

17.3

137

617

NDG30

NOMESCO Finland

Fusion of wrist, total

3.9

17.2

125

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

17.1

277

1598

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

17.1

2232

18848

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

17.1

226

1227

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.3

17.1

128

563

RS220, ,

NOMESCO Finland

2.7

17.0

347

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.9

17.0

210

1114

L95

ICPC

Osteoporosis

1.7

17.0

295

1736

R4120

NOMESCO Finland

Occupational therapy

1.6

17.0

437

2841

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

16.9

592

4108

B01AB04

ATC

dalteparin; parenteral

1.6

16.9

385

2433

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.3

16.9

124

541

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

16.8

1104

8529

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

5.3

16.8

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

16.8

540

3684

B03XA02

ATC

darbepoetin alfa; parenteral

2.0

16.8

184

938

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

4.5

16.8

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

3.7

16.8

141

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.9

16.8

218

1177

P01AB01

ATC

metronidazole; oral, rectal

1.2

16.8

2531

21707

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

16.7

515

3481

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.3

16.7

189

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

16.7

201

1058

GDA97

NOMESCO Finland

Other thoracoscopic incision, excision of lesion or repair of lung

35.1

16.6

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.4

16.5

109

453

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

7.3

16.5

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

3.4

16.5

176

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.7

16.5

299

1782

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

16.4

233

1293

E000001, ,

ATC

1.3

16.4

1257

9927

J99.1*M33.2

ICD-10 Finland

Respiratory disorders in polymyositis

40.1

16.3

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

3.5

16.3

158

XX1VW

NOMESCO Finland

Written report from radiologist

3.0

16.2

234

A02BA03

ATC

famotidine; systemic

1.7

16.2

303

1821

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

4.2

16.2

100

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

16.2

940

7129

C01BD01

ATC

amiodarone; systemic

1.8

16.1

253

1447

RS230, ,

NOMESCO Finland

3.8

16.1

131

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.4

16.1

164

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.6

16.1

282

4621

N06DX01

ATC

memantine; oral

0.6

16.1

376

5758

J98.9

ICD-10 Finland

Respiratory disorder, unspecified

5.3

16.0

R60.0

ICD-10 Finland

Localized oedema

1.3

16.0

1007

7731

N17.8

ICD-10 Finland

Other acute renal failure

2.3

16.0

121

535

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.6

15.9

146

TK810

NOMESCO Finland

Hemofiltration

3.2

15.9

200

WVA20

NOMESCO Finland

Medicine administration

1.9

15.9

208

1125

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

15.9

531

3650

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

15.9

161

798

A12AA04

ATC

calcium carbonate; oral

2.2

15.9

129

587

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.8

15.9

217

1191

WX720

NOMESCO Finland

Own respiration

1.6

15.9

342

2132

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.8

15.8

257

1485

B07.9

ICD-10 Finland

Verruca simplex

1.9

15.8

210

1143

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.0

15.8

165

828

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

2.6

15.7

344

GD1AA, ,

SPAT

1.4

15.7

806

5994

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

4.3

15.6

C08CA02

ATC

felodipine; oral

1.4

15.6

820

6117

C10AA05

ATC

atorvastatin; oral

1.2

15.6

3489

31074

N19

ICD-10 Finland

Unspecified kidney failure

1.6

15.6

348

2188

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.5

15.6

375

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.2

15.5

188

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

11.7

15.5

C10AA01

ATC

simvastatin; oral

1.2

15.5

3689

33045

V03AE01

ATC

polystyrene sulfonate; oral

2.2

15.5

126

574

AK3

BLTX (both lung transplants)

160.3

15.5

WW500

NOMESCO Finland

Blood transfusion

1.7

15.4

306

1867

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

15.4

2683

23306

C07AB02

ATC

metoprolol; systemic

1.3

15.4

1727

14304

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

15.3

839

6300

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.1

15.3

205

J01GB01

ATC

tobramycin; inhalant, parenteral

12.3

15.3

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

15.3

636

4559

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

3.3

15.3

165

ZY010

NOMESCO Finland

Hospital outpatient

1.8

15.2

247

1427

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.6

15.2

334

2091

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

13.0

15.1

L04AA11

ATC

[U] etanercept

4.5

15.1

A02BA02

ATC

ranitidine; systemic

1.3

15.1

1466

11929

J01XB01

ATC

colistin; inhalant, parenteral

23.4

15.1

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

2.7

15.0

283

Z94.3

ICD-10 Finland

Heart and lungs transplant status

45.1

15.0

L01BB01, ,

ATC

6.3

15.0

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

15.0

299

1828

J94.9

ICD-10 Finland

Pleural condition, unspecified

3.2

15.0

182

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.3

15.0

116

518

ZX121

NOMESCO Finland

Central venous catheter

4.3

15.0

N06AX11

ATC

mirtazapine; oral

1.2

14.9

2290

19622

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.6

14.9

354

2259

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.5

14.9

473

3218

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.0

14.9

165

846

3A064, ,

NOMESCO Finland

3.8

14.8

116

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.9

14.7

174

911

ZX197, ,

NOMESCO Finland

18.4

14.7

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.1

14.7

200

ZX100

NOMESCO Finland

Oral

2.2

14.6

116

524

GBB00

NOMESCO Finland

Tracheostomy

2.4

14.6

100

424

1CX08, ,

NOMESCO Finland

3.5

14.6

136

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

14.5

222

1262

L04AK01

ATC

leflunomide; oral

3.4

14.5

151

N06DA03

ATC

rivastigmine; oral, transdermal

0.5

14.4

162

2999

Coronary artery bypass surgery

1.8

14.4

223

1272

207

Kela drug reimbursment

Chronic arrhythmias

1.3

14.4

1474

12065

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.6

14.3

325

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.1

14.3

126

593

TNG10

NOMESCO Finland

Puncture of knee

2.5

14.3

337

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

14.3

1871

15748

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

14.3

410

2731

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

6.0

14.3

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

2.9

14.3

230

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.5

14.2

472

3241

UGC02

NOMESCO Finland

Rigid bronchoscopy

4.7

14.2

WX213

NOMESCO Finland

Lower leg blockade

2.7

14.1

281

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1.9

14.1

171

903

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.2

14.1

122

570

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

3.9

14.1

102

N06DA02

ATC

donepezil; oral

0.6

14.0

270

4325

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.5

14.0

417

2800

RT271, ,

NOMESCO Finland

6.7

14.0

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

14.0

676

4975

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

13.9

127

2512

SPAT1260

SPAT

Consultation of another employee

1.3

13.9

1212

9718

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

13.9

2300

19829

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

13.9

300

1871

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

13.9

721

5365

D07XC01

ATC

betamethasone; topical

1.3

13.9

837

6376

A01AB04

ATC

amphotericin B; local oral

1.6

13.9

337

2163

A06AD11

ATC

lactulose; oral

1.3

13.9

1275

10295

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

30.1

13.9

NG1DA

NOMESCO Finland

X-ray of knees

2.1

13.7

130

630

E000002, ,

ATC

1.4

13.7

610

4426

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

13.7

1470

12095

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.4

13.6

369

R01AD58

ATC

fluticasone, combinations; nasal

1.3

13.6

1199

9625

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

2.9

13.6

225

E84.9

ICD-10 Finland

Cystic fibrosis, unspecified

75.3

13.6

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

13.5

259

1567

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.8

13.5

208

1184

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.8

13.5

190

1053

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

34.1

13.5

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.5

13.4

404

2719

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

1.9

13.4

168

899

AA1AD

NOMESCO Finland

CT of head and brain

1.2

13.3

2379

20655

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

4.5

13.3

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

13.3

607

4424

I47.2

ICD-10 Finland

Ventricular tachycardia

1.9

13.3

172

930

R04

ICPC

Breathing problem other

1.7

13.2

262

1602

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

3.6

13.1

117

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

13.1

718

5392

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

13.0

361

2390

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

10.0

12.9

XX7LW, ,

NOMESCO Finland

5.2

12.9

R03DC01

ATC

zafirlukast; oral

2.1

12.9

115

545

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

12.8

3009

26769

WNF00

NOMESCO Finland

Infection source and contact determination

3.5

12.8

119

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

12.7

2569

22536

NDL52

NOMESCO Finland

Tenosynovectomy of hand

3.0

12.7

190

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.4

12.7

369

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

3.8

12.7

101

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

12.7

640

4742

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

12.6

1896

16160

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

12.6

191

1083

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

12.6

1682

14160

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.8

12.6

193

1098

NDG74

NOMESCO Finland

Fusion of first IP joint

4.4

12.6

XG422

NOMESCO Finland

Time-volume spirometry with bronchodialtation

6.0

12.6

196

Kela drug reimbursment

Paricalcitol and cinacalcet

3.4

12.6

130

WX727

NOMESCO Finland

Estimation of exercise oxygen therapy

32.1

12.6

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

3.3

12.5

140

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.4

12.5

510

3641

D11

ICPC

Diarrhoea

1.4

12.5

628

4647

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.0

12.5

130

652

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

2.7

12.5

247

A04

ICPC

Weakness/tiredness general

1.3

12.5

1119

8997

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

2.7

12.5

236

XX3DW

NOMESCO Finland

Time consuming IT work

1.3

12.5

765

5841

D07AD01

ATC

clobetasol; topical

1.3

12.4

1061

8479

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

12.4

498

3547

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

12.4

466

3279

WX204

NOMESCO Finland

Axillary plexus blockaced

1.7

12.4

207

1209

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

4.5

12.3

M25.5

ICD-10 Finland

Pain in joint

1.2

12.3

1960

16800

B01AF02

ATC

apixaban; oral

1.3

12.3

1172

9495

R03BB06

ATC

glycopyrronium bromide; inhalant

3.3

12.3

142

M06

ICD-10 Finland

Other rheumatoid arthritis

3.0

12.2

173

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

12.2

210

1235

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.9

12.2

160

868

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.5

12.2

335

2213

SBA10

NOMESCO Finland

Measurement of salivary flow rate

2.6

12.2

274

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.0

12.2

126

632

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

1.7

12.2

225

1351

DPA30

NOMESCO Finland

Sphenotomy

3.2

12.1

143

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.4

12.1

B01AC06

ATC

acetylsalicylic acid; oral

1.5

12.1

319

2088

C02KX04

ATC

macitentan; oral

12.4

12.1

4040, ,

NOMESCO Finland

12.4

12.1

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

4.0

12.1

RD210, ,

NOMESCO Finland

2.2

12.1

101

467

R4130

NOMESCO Finland

Speech therapy

1.8

12.1

191

1098

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.5

12.0

123

2341

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

12.0

528

3821

XQ848

NOMESCO Finland

Dermatological photography

1.7

12.0

214

1273

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

3.6

12.0

110

A12BA01

ATC

potassium chloride; oral

1.5

11.9

375

2548

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.2

11.9

457

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.2

11.9

102

477

R53

ICD-10 Finland

Malaise and fatigue

1.2

11.9

1756

14935

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

2.9

11.8

193

XG420

NOMESCO Finland

Time-volume spirometry

5.4

11.8

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.7

11.8

206

1219

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

2.9

11.7

183

J01FA01

ATC

erythromycin; systemic

1.4

11.7

673

5089

WX704

NOMESCO Finland

Intubation

1.4

11.7

519

3763

L03AA02

ATC

filgrastim; parenteral

1.7

11.7

197

1154

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

11.6

2993

26779

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

65.0

11.6

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.0

11.6

115

568

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

2.8

11.6

195

J99.1*M34.8

ICD-10 Finland

Respiratory disorders in systemic: sclerosis

22.9

11.5

H03AA01

ATC

levothyroxine sodium; systemic

1.2

11.5

1430

11934

D02AE01

ATC

carbamide; topical

1.5

11.5

386

2657

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.3

11.5

123

5168X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Other specified alveolar and parietoalveolar pneumopathies

+∞

11.5

51701

ICD-8 Finland

Other chronic interstitial pneumonia, Fibrosis interstitialis diffusa pulmonum essentialis (Hamman-Rich)

+∞

11.5

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

3.2

11.5

133

R05CB01

ATC

acetylcysteine; inhalant, oral

2.0

11.5

126

646

137

Kela drug reimbursment

Uraemia requiring dialysis

2.6

11.4

259

OAB50, ,

SPAT

1.4

11.4

567

4189

2770A

ICD-9 Finland

Other and unspecified disorders of metabolism, Cystic fibrosis

120.2

11.4

A07AA09

ATC

vancomycin; oral

2.0

11.4

112

551

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

4.8

11.4

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

5.4

11.3

R03AC18

ATC

indacaterol; inhalant

2.5

11.3

278

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.7

11.3

186

1082

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

15.0

11.3

N05CD07

ATC

temazepam; oral

1.3

11.3

913

7243

WX780

NOMESCO Finland

Remote monitoring CPAP

1.6

11.3

252

1588

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

11.3

108

527

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.5

11.3

322

2146

WPB10

NOMESCO Finland

Making a convalescent care decision

3.0

11.3

155

A07EC02

ATC

mesalazine; oral, rectal

1.5

11.2

297

1946

TQW11

NOMESCO Finland

Vacuum treatment of wound

1.9

11.2

146

793

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.5

11.2

324

2167

UJD02

NOMESCO Finland

Gastroscopy

1.5

11.1

340

2298

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

12.7

11.1

J67.8

ICD-10 Finland

Hypersensitivity pneumonitis due to other organic dusts

20.0

11.1

FXE00

NOMESCO Finland

Use of ECLA

20.0

11.1

F2682, ,

NOMESCO Finland

5.2

11.0

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

2.4

11.0

312

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.0

11.0

111

552

K77

ICPC

Heart failure

1.7

11.0

215

1311

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.8

11.0

1062

12970

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.4

10.9

462

3322

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

3.7

10.9

J93.9

ICD-10 Finland

Pneumothorax, unspecified

2.9

10.9

174

J01DA06

ATC

[U] cefuroxime

1.3

10.9

858

6781

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.9

10.9

136

728

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.7

10.9

175

1012

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.6

10.9

255

1626

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.1

10.9

102

494

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

10.8

576

4304

B59

ICD-10 Finland

Pneumocystosis

8.2

10.8

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

2.5

10.8

261

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

2.9

10.7

165

J98.6

ICD-10 Finland

Disorders of diaphragm

3.1

10.7

144

R06AX27

ATC

desloratadine; oral

1.2

10.7

1437

12088

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.1

10.7

438

ZY000

NOMESCO Finland

Hospital inpatient

2.6

10.7

227

SPAT1097

SPAT

Recording of ECG

1.3

10.7

1076

8770

G53.0

ICD-10 Finland

Postzoster neuralgia

2.5

10.6

245

304

Kela drug reimbursment

Dornase alfa

60.1

10.6

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

60.1

10.6

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

2.9

10.6

166

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

10.6

566

4232

NH1CM

NOMESCO Finland

Ankle and foot extensive MRI examination with 3 Tesla magnet

5.3

10.6

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.6

10.6

270

1757

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

2.8

10.5

183

RS224, ,

NOMESCO Finland

3.4

10.5

105

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.1

10.5

447

D68.8

ICD-10 Finland

Other specified coagulation defects

2.5

10.5

258

-1, ,

NOMESCO Finland

1.2

10.5

1830

15785

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

3.2

10.5

130

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

10.0

10.5

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

10.5

4416

40973

EB1WA, ,

NOMESCO Finland

2.9

10.4

168

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.5

10.4

285

1884

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.2

10.4

378

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

3.9

10.4

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.7

10.4

185

1102

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

2.3

10.3

315

SBA00

NOMESCO Finland

Microbiological examinations

1.8

10.3

158

901

R06AE09

ATC

levocetirizine; oral

1.3

10.3

697

5396

R11

ICD-10 Finland

Nausea and vomiting

1.4

10.3

555

4155

T90

ICPC

Diabetes non-insulin dependent

1.2

10.3

1895

16426

UJF92

NOMESCO Finland

Capsular endoscopy

1.9

10.2

128

686

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

2.8

10.2

175

C08CA01

ATC

amlodipine; oral

1.2

10.2

3165

28657

A10AE04

ATC

insulin glargine; parenteral

1.3

10.2

690

5342

SPAT1060

SPAT

Administration of oxygen

2.9

10.2

159

NHQ40

NOMESCO Finland

Amputation of toe

1.8

10.2

141

781

D05AX52

ATC

calcipotriol, combinations; topical

1.5

10.2

322

2194

B01AB10

ATC

tinzaparin; parenteral

1.3

10.1

715

5569

L28

ICPC

Limited function/disability (L)

1.2

10.1

1546

13165

J01DA08

ATC

[U] cefaclor

1.4

10.1

455

3308

NDG76

NOMESCO Finland

Fusion of DIP joint

2.6

10.1

222

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

1.7

10.1

166

968

51709

ICD-8 Finland

Other chronic interstitial pneumonia, Unspecified

8.4

10.0

742, ,

NOMESCO Finland

4.0

10.0

SPAT1254

SPAT

Administration of medicine

1.2

10.0

1093

8988

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

4.6

10.0

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

14.6

10.0

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

2.3

10.0

333

SPAT1059

SPAT

Spirometry at the office

1.5

10.0

331

2277

M54.5

ICD-10 Finland

Low back pain

1.2

9.9

2256

19908

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.0

9.9

491

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.6

9.9

212

1323

N06AA09

ATC

amitriptyline; systemic

1.3

9.9

620

4747

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.6

9.9

251

1631

S22.3

ICD-10 Finland

Fracture of rib

1.4

9.9

503

3732

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

9.8

1034

8462

H05BX01

ATC

cinacalcet; oral

2.7

9.8

196

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.0

9.7

103

522

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

1.8

9.7

144

814

XX9XW, ,

NOMESCO Finland

2.8

9.7

169

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

3.0

9.7

142

UDC00

NOMESCO Finland

Ear microscopy

1.4

9.7

480

3549

M05BA01

ATC

etidronic acid; systemic

2.8

9.6

170

OAA67, ,

SPAT

0.7

9.6

282

4121

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.3

9.6

573

4358

AP3

Catheterization of the right and left side of the heart

3.5

9.6

M48.0

ICD-10 Finland

Spinal stenosis

1.3

9.6

961

7822

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.2

9.6

1133

9394

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

9.6

434

3160

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

1.9

9.6

107

553

A10AB01

ATC

insulin (human); parenteral

1.6

9.6

189

1157

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

9.5

578

4406

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.7

9.5

157

916

RK250, ,

NOMESCO Finland

2.9

9.5

149

J01XX08

ATC

linezolid; systemic

2.6

9.5

211

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

9.1

9.5

DHA10

NOMESCO Finland

Biopsy of cavity of nose

2.5

9.5

229

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

9.4

2577

23073

B48.5

ICD-10 Finland

Pneumocystosis

30.0

9.4

SAA04

NOMESCO Finland

Special examination of mouth

1.5

9.4

272

1821

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

1.8

9.4

147

846

RK310, ,

NOMESCO Finland

5.1

9.3

J98.1

ICD-10 Finland

Pulmonary collapse

2.5

9.3

237

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.2

9.3

324

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

9.3

768

6106

J15

ICD-10 Finland

Bacterial pneumonia, not elsewhere classified

4.9

9.3

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

6.9

9.3

R52.0

ICD-10 Finland

Acute pain

1.7

9.2

179

1091

R07.3

ICD-10 Finland

Other chest pain

1.3

9.2

683

5354

E000003, ,

ATC

1.5

9.2

244

1602

5110B

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]

3.8

9.2

E66.8

ICD-10 Finland

Other obesity

1.5

9.2

240

1572

WW300

NOMESCO Finland

Transfer of autologic stem cells

3.5

9.2

A01AB10

ATC

natamycin; local oral

1.7

9.2

172

1040

Z01.9

ICD-10 Finland

Special examination, unspecified

1.4

9.1

380

2727

V03AE02

ATC

sevelamer; oral

2.9

9.1

147

R96

ICPC

Asthma

1.3

9.1

615

4760

AN4

Balloon angioplasty and drug eluding stent

1.5

9.1

260

1735

J43.1

ICD-10 Finland

Panlobular emphysema

7.7

9.1

D07AA02

ATC

hydrocortisone; topical

1.3

9.1

789

6311

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

5.0

9.1

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

5.0

9.1

M10

ICD-10 Finland

Gout

1.4

9.1

348

2462

GDA21

NOMESCO Finland

Thoracoscopic excision of lesion of lung

4.4

9.1

OAB43, ,

SPAT

0.8

9.0

528

6884

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

2.5

9.0

205

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

2.9

9.0

143

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

2.3

9.0

272

I26

ICD-10 Finland

Pulmonary embolism

2.2

8.9

304

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

18.6

8.9

B37.0

ICD-10 Finland

Candidal stomatitis

2.2

8.9

311

A40.0

ICD-10 Finland

Sepsis due to streptococcus, group A

3.5

8.9

AA1

Conventional CABG

1.7

8.9

171

1041

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.6

8.9

220

1424

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

8.9

786

6304

212

Kela drug reimbursment

Gout

1.7

8.9

171

1042

NDF10

NOMESCO Finland

Synovectomy of wrist

4.3

8.8

M01AH02

ATC

rofecoxib; oral

1.3

8.8

881

7164

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

2.0

8.8

444

S18

ICPC

Laceration/cut

1.2

8.8

3486

32026

3005

Kela drug reimbursment

Tofacitinib

4.5

8.8

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.5

8.8

252

1683

F03

ICD-10 Finland

Unspecified dementia

0.6

8.8

188

2933

SPAT1310

SPAT

Counselling related to known health issue

1.2

8.8

2076

18348

RK120, ,

NOMESCO Finland

3.5

8.8

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

10.7

8.8

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.4

8.8

395

2875

J01DA09

ATC

[U] cefadroxil

1.2

8.8

1591

13751

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

8.7

685

5409

UDM02

NOMESCO Finland

Sinoscopy

1.8

8.7

124

694

49300

ICD-8 Finland

Asthma, bronchiale

1.7

8.7

154

917

RJ420, ,

NOMESCO Finland

3.0

8.7

124

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

1.7

8.7

144

842

A07EA06

ATC

budesonide; oral, local oral

1.6

8.7

196

1241

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

2.7

8.7

168

C08DB01

ATC

diltiazem; oral

1.4

8.7

437

3239

E84.1

ICD-10 Finland

Cystic fibrosis with intestinal manifestations

50.0

8.7

4038, ,

NOMESCO Finland

50.0

8.7

5CM18, ,

NOMESCO Finland

3.0

8.7

119

B34.9

ICD-10 Finland

Viral infection, unspecified

1.7

8.7

137

791

AN2

Balloon angioplasty, including several vessels

1.6

8.6

216

1402

J37.0

ICD-10 Finland

Chronic laryngitis

1.6

8.6

194

1229

M79.6

ICD-10 Finland

Pain in limb

1.2

8.6

2868

26020

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.1

8.6

395

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.7

8.5

141

824

J70.3

ICD-10 Finland

Chronic drug-induced interstitial lung disorders

16.3

8.5

D83.9

ICD-10 Finland

Common variable immunodeficiency, unspecified

16.3

8.5

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

0.8

8.5

564

7229

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

9.0

8.5

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

8.5

159

961

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

3.4

8.5

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

1.6

8.5

166

1016

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.8

8.5

126

715

R03BB05

ATC

aclidinium bromide; inhalant

3.2

8.5

100

M31.7

ICD-10 Finland

Microscopic polyangiitis

6.4

8.5

R95

ICPC

Chron obstructive pulmonary disease

1.5

8.4

233

1545

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

1.5

8.4

230

1521

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.1

8.4

391

L17

ICPC

Foot/toe symptom/complaint

1.2

8.4

2070

18344

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.4

8.4

331

2353

XX4AW, ,

NOMESCO Finland

7.3

8.4

C61

ICD-10 Finland

Malignant neoplasm of prostate

0.8

8.4

595

7562

E84.8

ICD-10 Finland

Cystic fibrosis with other manifestations

90.2

8.4

P70

ICPC

Dementia

0.5

8.4

1430

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.4

8.4

380

2770

ZX140

NOMESCO Finland

Intra articular

2.4

8.4

219

M32

ICD-10 Finland

Systemic lupus erythematosus

7.8

8.3

1243

FHL

Bronchoscopy and other therapeutic procedure

6.7

8.3

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.6

8.3

167

1028

UGC08

NOMESCO Finland

Rigid bronchoscopy with biopsy of lung

+∞

8.3

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

8.3

401

2953

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.8

8.3

119

668

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

2.4

8.3

226

K08.3

ICD-10 Finland

Retained dental root

1.3

8.3

528

4057

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

2.7

8.3

150

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.0

8.3

435

R63.4

ICD-10 Finland

Abnormal weight loss

1.5

8.3

287

1995

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

1.8

8.2

107

583

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

3.8

8.2

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.0

8.2

395

D83.0

ICD-10 Finland

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

14.5

8.2

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

2.3

8.2

252

SPAT1211

SPAT

Application of soft bandage

1.3

8.2

563

4373

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.2

8.1

297

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

3.9

8.1

D05BB02

ATC

acitretin; oral

1.7

8.1

141

836

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.0

8.1

417

250, ,

Kela drug reimbursment

1.6

8.1

163

1005

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

2.0

8.1

404

A10AE05

ATC

insulin detemir; parenteral

1.4

8.1

338

2431

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

17.2

8.1

R78

ICPC

Acute bronchitis/bronchiolitis

1.7

8.1

126

726

K02.1

ICD-10 Finland

Caries of dentine

1.1

8.0

3530

32604

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.4

8.0

982

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

1.6

8.0

176

1109

A11

ICPC

Chest pain NOS

1.3

8.0

597

4686

Z94.4

ICD-10 Finland

Liver transplant status

3.6

8.0

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.6

8.0

159

978

Z31.5

ICD-10 Finland

Genetic counselling

1.5

8.0

205

1340

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

1.8

8.0

116

655

E87.5

ICD-10 Finland

Hyperkalaemia

1.7

7.9

150

910

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.8

7.9

121

692

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

2.8

7.9

142

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.2

7.9

1135

9588

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

2.8

7.9

131

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

7.9

958

7957

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.2

7.9

842

6897

R13

ICD-10 Finland

Dysphagia

1.3

7.9

492

3766

V03AE03

ATC

lanthanum carbonate; oral

3.2

7.9

N06AX16

ATC

venlafaxine; oral

1.3

7.9

662

5274

L03

ICPC

Low back symptom/complaint

1.2

7.9

1754

15411

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

7.9

2532

22877

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

6.6

7.9

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

7.8

1471

12740

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

2.4

7.8

226

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

1.8

7.8

103

564

C02KX01

ATC

bosentan; oral

10.8

7.8

L95.8

ICD-10 Finland

Other vasculitis limited to skin

3.4

7.8

C09DX04

ATC

valsartan and sacubitril; oral

2.0

7.8

376

N05BA04

ATC

oxazepam; oral

1.2

7.8

1701

14922

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

9.4

7.8

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

1.9

7.8

473

A04AA01

ATC

ondansetron; systemic, rectal

1.3

7.7

500

3849

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

4.2

7.7

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.5

7.7

215

1431

8041/3-C34.3

ICD-O-3

Small cell carcinoma, NOS, of lower lobe, lung

6.3

7.7

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.7

7.7

148

903

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.6

7.7

183

1176

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.2

7.7

872

7194

Z50.1

ICD-10 Finland

Other physical therapy

1.4

7.7

333

2411

RJ411, ,

NOMESCO Finland

2.6

7.7

162

R06AX22

ATC

ebastine; oral

1.2

7.7

848

6977

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

7.6

257

1776

WPA44

NOMESCO Finland

Nursing home for palliative care

3.2

7.6

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

3.0

7.6

112

R01AD01

ATC

beclometasone; nasal

1.2

7.6

841

6916

J01CF05

ATC

flucloxacillin; systemic

1.3

7.6

413

3099

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

7.6

1328

11425

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1.6

7.6

190

1235

602

Kela drug reimbursment

Children's severe malnutrition

11.8

7.6

M10.0

ICD-10 Finland

Idiopathic gout

1.4

7.6

273

1913

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

7.5

312

2240

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

2.7

7.5

146

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

1.7

7.5

123

718

R01

ICPC

Pain respiratory system

1.9

7.5

485

M01CC01

ATC

penicillamine; oral

4.1

7.5

L04AC14

ATC

sarilumab; systemic

6.1

7.5

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

2.9

7.5

113

7102A

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]

10.0

7.5

J62.0

ICD-10 Finland

Pneumoconiosis due to talc dust

10.0

7.5

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

7.5

189

1230

A05AA02

ATC

ursodeoxycholic acid; oral

2.0

7.5

395

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.4

7.5

325

2353

A02BA04

ATC

nizatidine; systemic

1.3

7.4

524

4083

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

1.7

7.4

116

669

RT274, ,

NOMESCO Finland

4.4

7.4

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

2.9

7.4

114

R4180

NOMESCO Finland

Podiatric therapy

2.0

7.4

404

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.4

7.4

195

TGA30

NOMESCO Finland

Thoracocentesis

2.1

7.4

323

GX1P5

NOMESCO Finland

Nocturnal CO2 monitoring

7.6

7.4

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

1.6

7.4

144

883

JN6AD

NOMESCO Finland

CT of torso and neck

1.7

7.4

118

686

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.1

7.3

2608

23701

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

4.0

7.3

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

1.6

7.3

157

985

B37.08

ICD-10 Finland

Other candidal stomatitis

2.2

7.3

278

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

2.5

7.3

178

PE1AT

NOMESCO Finland

Femoral artery PTA

1.8

7.3

100

555

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

7.3

2563

23274

6BB16, ,

NOMESCO Finland

+∞

7.3

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

3.0

7.3

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

3.1

7.3

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

7.3

1184

10123

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

3.2

7.2

C07AA07

ATC

sotalol; systemic

1.4

7.2

301

2164

M54

ICD-10 Finland

Dorsalgia

1.3

7.2

627

5017

49099

ICD-8 Finland

Bronchitis, unspecified

2.1

7.2

319

S29

ICPC

Skin symptom/complaint other

1.2

7.2

1361

11785

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.0

7.2

346

-44

ICPC

Preventive immunization/medic

1.3

7.2

564

4455

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.0

7.2

353

M01AX17

ATC

nimesulide; oral

1.2

7.2

1633

14360

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.3

7.2

437

3337

XJC00

NOMESCO Finland

Oesophageal manometry

3.0

7.2

100

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

1.7

7.2

127

759

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.1

7.1

327

R5599

NOMESCO Finland

Other rehabilitation service

1.6

7.1

163

1038

J99.1*M33.9

ICD-10 Finland

Respiratory disorders in dermatopolymyositis

30.0

7.1

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

7.1

560

4425

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

1.6

7.1

139

852

X58

ICD-10 Finland

Exposure to other specified factors

1.2

7.1

809

6675

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

1.6

7.1

149

930

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

3.4

7.1

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

6.5

7.1

J62.8

ICD-10 Finland

Pneumoconiosis due to other dust containing silica

7.9

7.1

J15.2

ICD-10 Finland

Pneumonia due to staphylococcus

7.9

7.1

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.3

7.1

388

2917

G04BE08

ATC

tadalafil; oral

3.3

7.1

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.3

7.1

391

2944

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

2.5

7.1

163

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.3

7.1

393

2962

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.1

7.1

302

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.1

7.1

302

N05CF02

ATC

zolpidem; oral

1.2

7.0

958

8052

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.4

7.0

245

1707

N02BF02

ATC

pregabalin; oral

1.3

7.0

381

2862

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

3.1

7.0

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

7.0

1172

10044

S22.2

ICD-10 Finland

Fracture of sternum

2.4

7.0

188

T92

ICPC

Gout

1.6

7.0

164

1052

C09CA01

ATC

losartan; oral

1.2

7.0

1916

17089

C83.1

ICD-10 Finland

Mantle cell lymphoma

2.7

7.0

135

RJ511, ,

NOMESCO Finland

3.9

7.0

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

1.7

7.0

118

697

TQW80

NOMESCO Finland

Local dermatologic skincare

1.6

7.0

170

1100

Z57.3

ICD-10 Finland

Occupational exposure to other air contaminants

3.4

7.0

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

1.8

6.9

499

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

1.8

6.9

101

572

A10BH01

ATC

sitagliptin; oral

1.3

6.9

686

5576

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

1.8

6.9

478

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

1.8

6.9

478

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

2.5

6.9

159

J21.99

ICD-10 Finland

Acute bronchiolitis, unspecified

3.7

6.9

K29.7

ICD-10 Finland

Gastritis, unspecified

1.5

6.9

226

1556

H26.02

ICD-10 Finland

Presenil cataract

1.6

6.9

146

914

R49.01

ICD-10 Finland

Functional dysphonia

1.6

6.9

160

1024

S81.7

ICD-10 Finland

Multiple open wounds of lower leg

2.9

6.9

108

SPAT1281

SPAT

Other administrative function

1.3

6.9

461

3569

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

1.7

6.9

120

715

Z49.2

ICD-10 Finland

Other dialysis

2.3

6.9

227

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.5

6.9

172

1120

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

2.0

6.8

353

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

2.0

6.8

360

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.4

6.8

254

1791

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

2.9

6.8

103

Catheterization and pressure measurement of the left side of the heart

1.6

6.8

135

831

N06AX21

ATC

duloxetine; oral

1.3

6.8

616

4953

F61.0

ICD-10 Finland

Mixed personality disorders

2.1

6.8

273

K51.5

ICD-10 Finland

Left sided colitis

1.7

6.8

128

778

TEA00

NOMESCO Finland

Biopsy of lip

2.1

6.8

300

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.5

6.8

216

1479

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.3

6.8

645

5218

N07BB01

ATC

disulfiram; oral

1.5

6.8

187

1244

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.4

6.8

260

1845

XV5WT, ,

NOMESCO Finland

40.0

6.8

JN4CD

NOMESCO Finland

Very extensive body CT

1.4

6.7

247

1737

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

2.6

6.7

149

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.2

6.7

1152

9887

5823

FHL

Lung avobiopsy and wedge resection

5.6

6.7

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.5

6.7

219

1506

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

2.2

6.7

242

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

6.7

615

4953

SPAT1301

SPAT

No procedures

1.1

6.7

2208

19938

Z71.8

ICD-10 Finland

Other specified counselling

1.2

6.7

2028

18205

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.6

6.7

148

936

M02AA07

ATC

piroxicam; topical

1.1

6.7

2504

22805

ZXE70

NOMESCO Finland

Moren than 15 and less than 18 hours

3.5

6.7

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

3.5

6.7

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.4

6.7

274

1966

116

Kela drug reimbursment

Prostate cancer

0.7

6.7

335

4463

I70.1

ICD-10 Finland

Atherosclerosis of renal artery

2.6

6.7

144

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

1.8

6.7

101

579

L30.3

ICD-10 Finland

Infective dermatitis

1.5

6.6

203

1380

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

2.3

6.6

193

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

4.0

6.6

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

4.0

6.6

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.6

6.6

136

846

J14

ICD-10 Finland

Pneumonia due to Haemophilus influenzae

7.8

6.6

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

3.0

6.6

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.6

1541

13572

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

1.9

6.6

414

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.1

6.6

3369

31287

B05DB

ATC

Hypertonic solutions

2.3

6.6

206

GD1DG

NOMESCO Finland

Extremely extensive MRI examination of pleura with high field magnet

12.2

6.6

N05BA01

ATC

diazepam; systemic, rectal

1.2

6.6

790

6557

D06BB04

ATC

podophyllotoxin; topical

1.6

6.5

148

942

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.1

6.5

2028

18234

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

3.3

6.5

B02.8

ICD-10 Finland

Zoster with other complications

2.2

6.5

245

GD1LA

NOMESCO Finland

1.7

6.5

107

627

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.9

6.5

444

J85.2

ICD-10 Finland

Abscess of lung without pneumonia

3.8

6.5

N03AX09

ATC

lamotrigine; oral

1.5

6.5

173

1142

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.2

6.5

1167

10059

B01AE07

ATC

dabigatran etexilate; oral

1.4

6.5

277

2003

B37.03

ICD-10 Finland

Chronic atrophic candida infection in the mouth

3.0

6.5

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

2.1

6.5

259

WVA20, ,

SPAT

1.5

6.5

216

1494

WW409

NOMESCO Finland

Other aferesis

3.6

6.5

R07.1

ICD-10 Finland

Chest pain on breathing

1.8

6.4

453

M05.0

ICD-10 Finland

Felty syndrome

5.3

6.4

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.4

6.4

274

1980

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

5.7

6.4

1512

Kela drug reimbursment

Ibrutinib

3.9

6.4

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

2.6

6.4

141

M05BB04

ATC

risedronic acid, calcium and colecalciferol, sequential; oral

3.5

6.4

D59.9

ICD-10 Finland

Acquired haemolytic anaemia, unspecified

3.5

6.4

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

3.5

6.4

AN3

Balloon angioplasty and metallic stent

1.5

6.4

207

1422

E000006, ,

ATC

1.3

6.4

378

2875

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

1.8

6.4

519

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.1

6.4

280

J01DC02

ATC

cefuroxime; systemic

1.4

6.4

256

1830

A10BA02

ATC

metformin; oral

1.1

6.4

2189

19808

R01AD05

ATC

budesonide; nasal

1.3

6.4

392

2999

L05

ICPC

Flank/axilla symptom/complaint

1.3

6.4

391

2992

N25.0

ICD-10 Finland

Renal osteodystrophy

3.0

6.4

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

2.4

6.4

178

D04AB01

ATC

lidocaine; topical

4.1

6.3

K59.1

ICD-10 Finland

Functional diarrhoea

1.3

6.3

336

2517

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.3

6.3

338

2535

B05DA

ATC

Isotonic solutions

2.2

6.3

223

M34

ICD-10 Finland

Systemic sclerosis

11.0

6.3

RF220, ,

NOMESCO Finland

1.8

6.3

486

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

1.8

6.3

486

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

9.2

6.3

A10AA01, ,

ATC

1.7

6.3

118

718

M81.8

ICD-10 Finland

Other osteoporosis

2.0

6.3

330

M60.9

ICD-10 Finland

Myositis, unspecified

2.4

6.3

173

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

2.2

6.3

217

M87.0

ICD-10 Finland

Idiopathic aseptic necrosis of bone

2.2

6.3

217

48609

ICD-8 Finland

Pneumonia, unspecified

1.9

6.3

386

RT272, ,

NOMESCO Finland

3.3

6.3

XG413

NOMESCO Finland

Spirometry with oscillometry

18.0

6.3

J86.00

ICD-10 Finland

Empyema with broncho-pleural fistula

3.8

6.2

A10BH05

ATC

linagliptin; oral

1.3

6.2

400

3080

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

6.2

1664

14800

XG430

NOMESCO Finland

Spiroegometry

7.0

6.2

M31.0

ICD-10 Finland

Hypersensitivity angiitis

7.0

6.2

A01

ICPC

Pain general/multiple sites

1.2

6.2

639

5218

K07

ICPC

Swollen ankles/oedema

1.3

6.2

355

2690

M87.9

ICD-10 Finland

Osteonecrosis, unspecified

2.4

6.2

174

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

3.7

6.2

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

0.7

6.2

147

2232

M10.3

ICD-10 Finland

Gout due to impairment of renal function

2.4

6.2

162

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

2.5

6.2

144

M01AE02

ATC

naproxen; oral, rectal

1.1

6.2

3507

32736

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

2.9

6.1

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

2.2

6.1

232

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.5

6.1

156

1021

K93

ICPC

Pulmonary embolism

1.9

6.1

382

R03DX09

ATC

mepolizumab; parenteral

7.7

6.1

D84.9

ICD-10 Finland

Immunodeficiency, unspecified

7.7

6.1

E000007, ,

ATC

1.4

6.1

255

1839

D02AX

ATC

Other emollients and protectives

1.6

6.1

149

967

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.4

6.1

254

1831

C10AC01

ATC

colestyramine; oral

1.5

6.1

152

991

NCF10

NOMESCO Finland

Synovectomy of elbow joint, open

4.1

6.1

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

4.1

6.1

390

Kela drug reimbursment

Ibrutinib

3.8

6.1

WPB11

NOMESCO Finland

Palliative sedation

12.5

6.1

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.6

6.1

133

841

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

6.1

173

1160

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

3.0

6.1

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

1.7

6.0

551

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.1

6.0

2353

21459

A03FA02

ATC

cisapride; oral, rectal

1.3

6.0

491

3900

QDB00

NOMESCO Finland

Suture of skin of lower limb

2.3

6.0

176

XX9TE

NOMESCO Finland

Compementary ultrasound examination

2.3

6.0

176

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

1.9

6.0

377

E66.01

ICD-10 Finland

Obesity due to excess calories

1.3

6.0

391

3016

N30.2

ICD-10 Finland

Other chronic cystitis

2.0

6.0

287

251, ,

Kela drug reimbursment

10.0

6.0

1500

FHL

Thoracoscopy

10.0

6.0

M31.1

ICD-10 Finland

Thrombotic microangiopathy

6.7

6.0

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

1.6

6.0

119

734

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

1.7

6.0

113

688

K11.2

ICD-10 Finland

Sialoadenitis

1.5

6.0

175

1179

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.0

6.0

301

M01AB55

ATC

diclofenac, combinations; oral

1.3

6.0

439

3441

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

638

1215

5.60

320.01

1.4

1.2

57.61

44.86

u/ml

0.88

121

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

454

624

7.63

313.34

2.0

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

479

700

7.20

312.91

1.3

56.94

45.12

u/ml

0.33

(3000494) Fungus identified in Specimen by Culture

2008

8554

2.77

309.81

2.3

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

765

1757

4.69

308.49

1.8

1.9

11.82

12.64

mg/l

1.05

717

1617

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1546

2598

7.07

307.65

1.4

1.2

—

(3001604) Monocytes [#/volume] in Blood

6112

36654

3.47

307.65

12.7

5.9

0.67

0.62

e9/l

31.78

5562

30852

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2758

11095

3.21

307.65

2.6

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1327

1896

8.13

307.65

2.3

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

415

208

20.94

307.65

1.8

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

676

899

8.09

307.65

2.5

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

932

1939

5.28

307.65

1.9

1.5

1.19

1.18

g/l

0.77

905

1849

(3006184) Hemoglobin [Mass/volume] in Capillary blood

920

2039

4.94

307.65

2.7

2.3

126.62

127.45

g/l

0.31

477

1631

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

678

1019

7.15

307.65

1.2

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1388

2442

6.61

307.65

2.1

1.6

7.33

6.79

iu/ml

0.24

320

594

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

989

1619

6.79

307.65

1.4

1.2

6.49

4.63

u/ml

0.25

121

158

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

418

455

9.62

307.65

2.0

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

3224

8393

5.62

307.65

1.5

1.3

564.08

504.32

titre

1.01

952

1814

(3027801) Oxygen [Partial pressure] in Arterial blood

2492

10405

2.99

307.65

10.6

7.3

10.32

12.09

kpa

74.15

2409

9963

(44806118) Parainfluenza type 4 nucleic acid detection

676

899

8.09

307.65

2.5

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

332

146

23.64

307.65

1.1

—

(3042631) Mycobacterium sp identified in Specimen

784

1124

7.59

307.65

2.9

2.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1168

2820

4.65

307.65

1.8

38.65

38.80

u/l

0.08

1069

2428

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1810

2969

7.50

307.65

3.1

2.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2935

11124

3.52

307.65

1.4

1.3

59.42

35.58

iu/ml

6.09

1007

3307

(3005322) IgE [Units/volume] in Serum or Plasma

1312

3663

4.06

307.65

1.7

1.3

251.08

260.65

u/ml

0.12

1236

3363

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

979

1625

6.69

307.65

1.4

1.3

12.33

6.45

u/ml

1.45

184

245

(3002030) Lymphocytes/Leukocytes in Blood

5797

34520

3.20

307.65

13.4

6.2

24.24

26.09

31.47

5708

32420

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1960

3044

8.10

307.65

1.7

1.5

14.13

16.64

iu/ml

0.19

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

415

438

9.92

307.65

2.0

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1003

1722

6.48

307.65

1.4

1.2

41.24

49.70

u/ml

0.29

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

554

655

8.99

307.65

1.2

1.1

68.57

34.39

u/ml

1.26

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

939

1382

7.53

307.65

1.3

1.2

16.22

1.91

u/ml

2.16

(3022096) Basophils/Leukocytes in Blood

5764

33940

3.24

307.65

13.5

6.3

0.63

0.65

1.98

5664

31489

(3006504) Eosinophils/Leukocytes in Blood

5783

33920

3.27

307.65

13.3

6.2

2.78

2.85

1.56

5682

31480

(3023368) Bacteria identified in Blood by Culture

4260

24494

2.50

307.65

6.5

4.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

928

1876

5.44

307.65

1.9

1.5

0.23

0.24

g/l

2.10

897

1787

(3019069) Monocytes/Leukocytes in Blood

5788

34018

3.27

307.65

13.5

6.3

8.98

9.15

4.47

5690

31565

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

544

856

6.73

307.65

1.2

1.1

30.62

6.82

u/ml

1.59

(44790049) Parainfluenza type 3 nucleic acid detection

676

899

8.09

307.65

2.5

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

332

146

23.64

307.65

1.1

—

(3006315) Basophils [#/volume] in Blood

6118

36809

3.45

307.65

12.7

5.9

0.04

e9/l

8.41

5570

31013

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3318

14815

3.05

307.65

2.8

1.9

—

(44790048) Parainfluenza type 2 nucleic acid detection

676

899

8.09

307.65

2.5

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1205

2054

6.68

307.65

1.7

1.4

15.15

15.98

iu/ml

0.06

(3018010) Neutrophils/Leukocytes in Blood

5731

33785

3.20

307.65

12.9

6.1

60.61

58.49

33.45

5661

32007

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

777

958

8.84

307.65

2.2

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1236

2192

6.44

307.65

1.3

1.2

1.74

0.92

u/ml

0.88

101

193

(3028026) IgM [Mass/volume] in Serum or Plasma

1449

4114

4.05

307.65

2.2

1.9

1.11

1.35

g/l

4.97

1361

3709

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

818

952

9.41

307.65

2.4

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

6209

41265

2.95

307.65

16.6

9.2

4.74

4.31

e9/l

34.20

5695

35373

(3019977) pH of Arterial blood

2469

10373

2.96

307.65

10.8

7.4

7.42

3.57

1557

5724

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

923

1158

8.83

307.65

1.8

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1312

1607

9.49

307.65

2.0

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

821

1151

7.80

307.65

1.4

1.3

14.72

9.93

u/ml

0.54

(3003396) Base excess in Arterial blood by calculation

2465

10308

2.97

307.65

10.6

7.3

1.40

0.94

mmol/l

5.92

2107

8407

(3013115) Eosinophils [#/volume] in Blood

6184

37820

3.42

307.65

13.5

6.1

0.21

0.20

e9/l

7.78

5700

32345

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

557

831

7.11

307.65

3.5

3.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2774

10300

3.53

307.65

1.4

1.3

24.73

12.55

u/ml

3.33

842

3766

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1337

1925

8.07

307.65

2.2

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

976

1318

8.25

307.65

2.2

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1864

5199

4.32

307.65

4.3

2.7

10.35

10.68

g/l

2.03

1795

4763

(42529582) MDA5 Ab [Presence] in Serum by Line blot

332

146

23.64

307.65

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1645

5482

3.49

307.65

2.1

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2495

10410

2.99

307.65

10.6

7.3

5.05

5.07

kpa

0.38

2411

9980

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

332

146

23.64

307.65

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

808

1383

6.36

307.65

1.3

1.2

170.00

126.96

titre

0.18

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

813

1361

6.51

307.65

11.8

4.6

1141.47

1787.57

iu/ml

0.18

191

181

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

808

1383

6.36

307.65

1.3

1.2

279.42

308.23

titre

0.14

110

(3019198) Lymphocytes [#/volume] in Blood

6135

37399

3.39

307.65

12.9

6.0

1.88

1.87

e9/l

0.11

5654

32247

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1424

1781

9.43

307.65

1.8

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1179

1387

9.73

307.65

2.0

1.3

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

616

800

8.23

307.65

1.2

1.1

9.12

20.60

u/ml

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

440

513

9.00

307.65

2.0

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2628

10300

3.26

307.65

2.7

1.9

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

1042

464

25.50

307.65

2.0

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

705

272

28.21

307.65

1.1

—

(3023419) Bacteria identified in Sputum by Culture

872

987

9.74

307.65

2.7

2.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

995

1410

7.87

307.65

1.8

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1375

1451

11.14

307.65

1.3

1.2

50.66

0.53

u/ml

4.89

(3016502) Oxygen saturation in Arterial blood

2125

9368

2.70

306.09

11.3

7.6

93.80

95.41

21.62

2059

9032

(46235355) HIV 1 and 2 tests - Meaningful Use set

1907

7974

2.80

304.39

1.8

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

584

1096

5.65

297.25

5.2

2.3

601.00

1953.79

u/ml

1.09

(3017181) Myelocytes/Leukocytes in Blood

1725

6946

2.87

294.81

6.7

4.1

0.86

0.97

1.28

745

2234

(3002179) Metamyelocytes/Leukocytes in Blood

1649

6579

2.88

285.95

6.5

4.0

0.63

0.74

1.08

697

2101

(3027135) IgG subclass 1 [Mass/volume] in Serum

428

630

7.11

277.41

1.4

1.3

7.26

6.88

g/l

0.73

298

451

(3028192) IgG subclass 2 [Mass/volume] in Serum

427

630

7.09

276.15

1.4

1.3

2.94

g/l

0.02

301

455

(3024139) IgG subclass 3 [Mass/volume] in Serum

427

630

7.09

276.15

1.4

1.3

0.47

0.42

g/l

1.14

298

455

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4382

27614

2.23

274.40

4.6

3.4

2030.51

1766.32

ng/l

2.39

4002

24137

(3042936) Bacteria identified in Isolate by Culture

2351

11422

2.47

272.20

2.6

2.0

—

(4062490) Immunoglobulin typing, IgG

416

618

7.03

267.26

1.4

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

545

1057

5.44

267.17

1.7

1.6

0.95

0.86

g/l

0.60

399

818

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

175

29.77

264.49

2.9

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1395

5289

2.96

264.03

11.9

9.1

24.63

24.23

mmol/l

4.17

1355

5143

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5696

40382

2.28

260.34

10.5

6.6

11.36

12.47

umol/l

8.27

5566

38480

(3021440) Promyelocytes/Leukocytes in Blood

1607

6637

2.76

258.70

6.9

4.1

0.07

0.12

2.78

621

1935

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1122

3804

3.25

257.35

2.6

1.9

1.95

2.32

ug/l

0.35

1028

3330

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

432

699

6.46

255.71

2.0

1.6

—

(3025159) Blasts/Leukocytes in Blood

1600

6636

2.74

255.17

7.0

4.3

0.21

0.28

0.22

604

1818

(3004616) Nuclear Ab [Presence] in Serum

455

781

6.10

253.84

1.4

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

442

745

6.21

251.16

2.0

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

381

563

7.04

245.81

1.3

1.1

78.08

73.29

u/ml

0.07

(3018418) pH of Serum or Plasma

3882

24374

2.10

232.65

6.6

4.3

7.40

1.74

2962

17642

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

246

225

11.23

231.94

2.0

1.7

38125.72

29705.10

u/ml

0.08

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5204

36493

2.12

231.22

12.0

6.8

1.20

1.21

mmol/l

9.62

4977

33533

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1427

5856

2.73

230.47

6.1

3.8

5.16

5.14

kpa

0.30

1387

5548

(3009343) pH of Capillary blood

1394

5696

2.74

226.78

6.1

3.8

7.42

5.51

1216

4719

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

309

410

7.79

219.31

4.0

3.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1498

6459

2.61

218.16

2.2

2.4

340.76

387.79

nmol/l

12.13

1431

5942

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1808

8605

2.40

212.37

13.0

8.1

121.78

120.08

g/l

2.65

1773

8410

(40760892) CBC W Ordered Manual Differential panel - Blood

2613

14588

2.15

208.11

9.6

4.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1245

5002

2.75

208.10

5.8

3.7

2.27

1.83

mmol/l

3.79

988

3662

(3015235) Bicarbonate [Moles/volume] in Capillary blood

912

3117

3.16

204.29

4.6

3.0

25.21

24.73

mmol/l

2.80

892

3062

(1616796) Gas panel - Central venous blood

672

1902

3.75

202.56

5.7

3.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

332

520

6.61

202.46

1.3

1.1

—

(3021901) Oxygen saturation in Capillary blood

661

1875

3.74

198.51

4.5

2.9

88.43

89.10

1.52

648

1822

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5517

40722

2.04

198.05

13.2

7.5

1.20

1.21

mmol/l

8.10

4835

35004

(3021589) Normoblasts [#/volume] in Blood

4535

31357

1.97

195.36

23.1

12.4

0.00

e9/l

0.53

3846

25351

(3028626) Oxygen [Partial pressure] in Capillary blood

719

2214

3.46

190.47

5.2

3.2

7.66

7.95

kpa

5.34

704

2161

(3038026) Centromere Ab [Units/volume] in Serum

312

489

6.59

190.07

1.3

1.2

49.51

62.46

u/ml

0.27

(3011412) CD3 cells [#/volume] in Blood

346

610

5.87

187.26

2.2

1030.50

1078.68

e6/l

0.44

312

546

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

348

620

5.81

186.27

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

348

620

5.81

186.27

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

348

620

5.81

186.27

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2245

12253

2.14

186.13

2.0

1.5

2.79

2.62

g/l

2.71

1638

7097

(3017143) Hepatitis C virus Ab [Presence] in Serum

1377

6118

2.50

185.93

1.8

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2438

13734

2.09

185.90

6.5

3.1

0.81

mmol/l

0.17

2311

12859

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

666

1997

3.54

183.69

1.6

1.5

46.47

4.07

iu/ml

0.93

134

420

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

492

1192

4.32

183.55

1.5

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2666

15580

2.04

183.51

2.5

1.7

1.58

1.46

mg/l

0.74

2237

12271

(3020779) Urea [Moles/volume] in Serum or Plasma

1680

8204

2.31

183.13

12.6

6.8

11.44

11.14

mmol/l

0.84

1620

7792

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

297

460

6.66

182.97

1.3

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

483

1188

4.25

176.56

1.5

1.4

35.97

16.71

u/ml

1.80

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1031

4090

2.73

174.92

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

609

1782

3.61

174.13

3.7

2.7

15.57

16.08

3.26

597

1746

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

6511

52143

2.11

172.46

10.1

4.5

18.56

13.86

mm/h

82.88

6361

48163

(3042733) HLA Ab [Presence] in Serum

174

148

11.98

171.87

4.5

4.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1499

7176

2.33

170.00

1.8

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

441

1046

4.39

168.94

1.5

1.4

152.72

155.90

au/ml

0.19

124

296

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

327

602

5.61

168.92

1.4

1.1

—

(1175426) CD3 cells/Lymphocytes in Blood

290

484

6.17

165.92

2.1

2.0

72.73

71.26

0.67

278

457

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

283

465

6.26

164.47

2.2

2.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1238

5543

2.45

162.83

13.1

7.8

24.97

24.77

mmol/l

0.92

1226

5495

(40759836) Histone Ab [Presence] in Serum by Immunoblot

276

452

6.28

160.91

1.3

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

263

411

6.57

160.54

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

269

432

6.40

159.89

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

265

420

6.48

159.56

1.3

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1237

5587

2.42

159.36

9.9

6.7

24.96

24.46

mmol/l

4.10

1200

5348

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

271

442

6.30

158.63

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

271

442

6.30

158.63

1.3

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

276

461

6.16

157.75

2.0

15.90

16.69

0.44

269

446

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2021

11291

2.04

152.97

9.7

5.8

1.07

1.04

mmol/l

3.91

1911

10457

(3024561) Albumin [Mass/volume] in Serum or Plasma

4864

36189

1.82

149.17

7.5

5.1

33.37

34.83

g/l

55.27

4610

33684

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

631

2083

3.19

148.41

3.6

2.3

3.86

3.60

g/l

3.34

617

1983

(3022948) Iron [Moles/volume] in Serum or Plasma

2455

14812

1.93

148.06

3.5

2.7

11.49

12.21

umol/l

5.09

2319

13660

(3032080) INR in Blood by Coagulation assay

5158

39128

1.83

147.65

20.6

19.1

1.33

1.35

inr

1.31

4469

33060

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

250

404

6.35

147.64

1.5

1.3

1.58

2.12

u/ml

0.33

171

238

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2214

12943

1.97

146.34

3.5

2.7

20.93

21.71

1.79

2087

11930

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3424

23062

1.82

145.07

5.1

3.2

35.28

35.92

u/l

0.16

3280

21597

(36304419) Bacteria [Presence] in Urine

3264

21726

1.82

143.33

4.9

3.5

0.45

118.71

estimate

0.63

131

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2328

13932

1.93

143.00

3.5

2.7

2.22

2.26

g/l

1.99

2176

12768

(21494815) CD4 cells/Lymphocytes in Specimen

282

535

5.42

140.83

2.2

2.1

39.15

38.03

0.47

277

525

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1451

7409

2.16

137.99

4.4

3.1

260.87

238.16

ng/l

0.98

1361

6836

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1877

10562

2.00

137.25

4.9

4.2

264.34

247.50

u/l

4.37

1798

9961

(3024932) HLA-DR beta [Type]

148

139

10.82

136.86

1.0

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1277

6218

2.24

136.63

1.9

1.7

—

(3024471) HLA-A [Type]

149

143

10.59

135.74

1.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1504

7833

2.12

135.68

2.5

2.6

65.75

65.89

g/l

0.29

1415

7065

(3030467) Casts [#/volume] in Urine by Automated count

3380

23143

1.77

131.86

5.0

3.5

0.42

0.48

e6/l

0.82

2666

17417

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

195

274

7.26

131.34

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

155

165

9.55

131.06

2.7

1.3

—

(3026782) Osmolality of Urine

2544

16149

1.83

127.09

4.1

3.1

516.07

536.93

mosm/kgh2o

6.47

2336

14183

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1082

5064

2.31

126.64

16.2

9.6

15.81

15.88

0.36

1046

4892

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

212

339

6.39

126.45

1.4

1.1

—

(3000991) Gas panel - Venous blood

1443

7582

2.09

126.34

14.2

8.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

188

265

7.23

126.26

3.5

1.8

45.31

59.19

ug/l

1.94

188

256

(3018095) Leukocytes [#/volume] in Urine

4035

29323

1.73

125.35

6.4

4.3

105.82

113.77

e6/l

0.17

3131

21468

(3026250) Tacrolimus [Mass/volume] in Blood

174

228

7.77

124.60

47.0

36.4

7.89

7.25

ug/l

2.53

158

201

(3002582) Erythrocytes [#/volume] in Urine

3757

26809

1.73

124.39

5.2

3.7

85.37

100.25

e6/l

0.18

3054

20869

(3027315) Oxygen [Partial pressure] in Blood

528

1742

3.17

123.85

7.2

4.1

8.25

8.45

kpa

1.85

518

1694

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

4030

29359

1.72

123.37

5.3

3.7

—

1.79

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

643

2385

2.84

122.45

1.8

1.7

—

(3010503) CD19 cells [#/volume] in Blood

229

409

5.73

122.02

2.3

100.57

108.55

e6/l

0.23

222

391

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6660

56087

1.91

121.05

16.1

8.4

81.31

81.94

u/l

0.38

6536

53028

(3012501) Base excess in Blood by calculation

522

1735

3.14

120.86

7.3

4.1

2.78

2.63

mmol/l

0.61

400

1174

(3013290) Carbon dioxide [Partial pressure] in Blood

522

1736

3.14

120.74

7.3

4.1

5.02

4.99

kpa

0.50

512

1689

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

571

2003

2.99

120.36

3.6

2.1

89.73

89.64

0.03

559

1928

(3017569) Oxygen content in Arterial blood

252

501

5.15

119.33

2.3

2.1

16.30

15.84

1.14

252

501

(3014111) Lactate [Moles/volume] in Serum or Plasma

1468

7927

2.03

118.62

12.4

7.2

1.42

1.37

mmol/l

0.93

1435

7748

(3010421) pH of Blood

679

2660

2.69

116.24

6.5

3.7

7.42

7.41

2.40

669

2617

(3010375) cycloSPORINE [Mass/volume] in Blood

177

257

7.01

115.69

43.8

25.2

147.66

103.58

ug/l

8.96

140

211

(3000850) Epithelial cells [#/volume] in Urine

2827

18919

1.75

115.57

3.9

2.9

4.62

4.56

e6/l

0.07

2639

17233

(3013826) Glucose [Moles/volume] in Serum or Plasma

5642

45509

1.73

114.83

10.0

5.3

6.93

6.85

mmol/l

1.99

5477

43441

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

370

1024

3.73

114.24

1.3

1.2

324.49

278.84

u/ml

1.27

238

618

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

291

676

4.42

114.15

1.4

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

208

362

5.87

113.87

1.7

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

208

362

5.87

113.87

1.7

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

208

362

5.87

113.87

1.7

1.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

528

1838

3.00

112.68

3.9

2.4

214.42

206.20

1.12

506

1750

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

206

362

5.81

111.64

1.7

1.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

216

398

5.54

111.29

2.1

2.2

487.71

498.80

e6/l

0.09

167

324

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1125

5636

2.15

110.46

2.1

1.8

—

(3033099) Centromere Ab [Titer] in Serum

124

10.13

109.71

1.2

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1596

9100

1.93

109.33

5.7

3.7

5.87

5.80

kpa

1.71

1547

8864

(3002032) Base excess in Venous blood by calculation

1562

8843

1.94

109.30

5.7

3.8

2.13

1.76

mmol/l

3.36

1375

7655

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

173

262

6.72

108.72

1.7

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

173

262

6.72

108.72

1.7

2.0

—

(3017732) Neutrophils [#/volume] in Blood

1568

8913

1.93

108.30

3.9

3.3

4.69

4.79

e9/l

0.26

1419

7448

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

326

858

3.91

108.14

1.3

1.2

5.56

3.60

u/ml

0.49

145

292

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

14.70

107.44

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

212

398

5.44

107.02

2.2

2.3

213.31

234.95

e6/l

0.60

183

345

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

172

264

6.63

106.72

1.7

2.0

—

(40757373) Influenza virus identified in Isolate

128

139

9.34

106.60

2.6

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2463

16148

1.74

106.46

5.7

4.3

420.23

487.78

ng/l

0.38

2194

13826

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

242

514

4.82

106.04

2.3

2.4

37.23

25.09

iu/ml

0.50

(3012544) pH of Venous blood

1604

9250

1.91

105.80

5.8

3.8

7.38

0.33

967

5463

(3028271) Lactate [Moles/volume] in Capillary blood

416

1308

3.29

105.43

2.3

1.9

1.66

1.71

mmol/l

0.43

408

1272

(3027945) Reticulocytes/Erythrocytes in Blood

1831

11045

1.84

104.72

3.6

2.4

1.95

1.76

10.62

1646

9714

(3022313) Gas panel - Capillary blood

868

4023

2.29

102.86

6.6

4.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3486

25307

1.65

101.37

3.5

2.2

161.21

229.25

u/l

5.51

3326

23809

(40758558) Short blood count panel - Blood

3106

21938

1.66

100.34

10.4

6.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

156

231

6.86

100.12

2.1

1.9

1.85

1.67

ratio

0.50

146

221

(21494814) CD8 cells/Lymphocytes in Specimen

168

271

6.31

99.32

2.1

2.0

30.72

32.15

0.45

168

271

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

101

11.47

97.40

1.3

1.2

39.97

45.39

mg/l

0.36

(3048929) Epstein Barr virus Ab [Presence] in Serum

436

1477

3.06

97.39

1.3

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

307

842

3.75

95.94

1.3

1.2

5.02

4.20

u/ml

0.29

183

371

(3036489) Thrombin time

620

2551

2.54

95.55

3.4

1.9

21.57

21.49

0.09

576

2293

(3008536) Aspergillus sp Ab [Presence] in Serum

119

137

8.80

94.74

1.6

1.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2892

20356

1.64

92.88

4.9

3.0

364.56

358.30

umol/l

2.26

2599

17581

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

225

502

4.58

92.82

1.3

1.2

150.00

138.82

titre

0.10

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

225

502

4.58

92.82

1.3

1.2

105.71

117.50

titre

0.14

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

286

768

3.82

92.13

1.3

1.1

116.68

113.89

0.64

274

678

(3014007) Fractional oxyhemoglobin in Arterial blood

1100

5842

2.02

91.20

15.5

9.3

92.45

93.89

11.30

1093

5821

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1370

7849

1.89

90.82

2.4

2.2

0.20

g/l

1.30

1269

7278

(3015377) Calcium [Moles/volume] in Serum or Plasma

3629

27115

1.60

90.48

4.5

3.5

2.34

2.35

mmol/l

4.86

3379

24342

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2023

13040

1.73

90.33

3.0

2.0

30.11

29.99

0.33

1973

12671

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

711

3204

2.33

89.52

4.0

2.8

0.32

0.34

iu/ml

1.52

420

1757

(3023520) Reticulocytes [#/volume] in Blood

1472

8677

1.84

89.03

3.5

2.5

72.65

67.63

e9/l

4.88

1038

6466

(4195642) Thrombophilia screening test

280

759

3.78

88.97

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

140

211

6.73

88.38

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

190

385

5.03

87.98

1.2

88.69

82.62

0.75

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

986

5120

2.05

86.75

5.6

3.8

24.31

24.10

mmol/l

1.19

975

5050

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1057

5661

1.99

85.21

15.9

9.4

0.60

0.63

1.49

1046

5626

(3014148) Varicella zoster virus Ab [Titer] in Serum

231

564

4.18

84.85

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

2726

19238

1.62

84.78

7.0

4.3

84.40

84.56

0.12

2679

18829

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

238

597

4.07

84.30

1.2

95.10

95.26

0.03

231

553

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3049

22143

1.59

83.89

2.8

2.4

3.05

2.93

mg/l

2.14

2716

18952

(3009871) Measles virus Ab [Titer] in Serum

123

171

7.28

83.62

1.4

1.7

2120.00

3859.31

titre

1.36

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1078

5850

1.97

83.56

15.6

9.1

1.34

1.30

0.70

1066

5817

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

463

1763

2.72

83.23

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

463

1763

2.72

83.23

1.5

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

5879

49714

1.61

82.30

7.3

4.9

2.30

2.06

—

(4268621) Lupus anticoagulant assay

232

584

4.06

81.78

2.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4151

32474

1.55

81.57

3.3

2.4

77.64

79.01

nmol/l

2.55

3852

28699

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

276

807

3.50

78.32

1.2

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

702

3332

2.21

77.70

3.0

3.2

72.54

75.48

mg/l

0.05

546

2853

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

177

378

4.76

77.03

2.0

1.6

5.94

6.67

u/l

0.60

160

323

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

700

3330

2.20

77.02

3.0

3.2

44.90

52.34

mg/l

0.72

542

2847

(3046861) Legionella sp Ag [Presence] in Urine

15.46

75.95

1.1

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

176

386

4.64

74.16

2.5

2.6

38.14

37.08

0.25

105

212

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

862

4539

2.00

72.28

2.2

1.6

1.62

1.56

g/l

0.91

744

3870

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

234

651

3.67

71.56

1.1

1.78

2.44

iu/ml

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

634

2994

2.21

70.87

3.0

3.1

2.29

4.61

ratio

1.14

318

1790

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

797

4121

2.03

70.24

8.0

4.9

1.72

1.58

4.99

759

3912

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4274

34370

1.50

69.01

3.2

2.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1130

6599

1.82

68.95

5.8

4.0

1.22

1.23

mmol/l

4.61

1033

5648

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

177

414

4.35

68.79

2.3

2.2

0.56

0.64

e9/l

0.87

159

391

(3021601) Nitrite [Presence] in Urine by Test strip

4666

38237

1.50

68.39

5.5

4.2

0.00

estimate

1.60

1328

8171

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4028

32055

1.49

68.12

4.1

3.1

197.87

152.74

ug/l

10.78

3748

29343

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

663

3241

2.14

67.83

3.2

2.2

346.91

675.24

ug/l

2.90

635

3098

(3035350) Ketones [Presence] in Urine by Test strip

4712

38735

1.49

67.69

5.5

4.2

7.24

4.54

estimate

0.45

1358

8437

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

843

4505

1.97

67.55

1.7

1.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5716

48922

1.53

67.43

6.8

5.3

1215.16

2063.80

e6/l

0.63

797

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

123

214

5.82

67.37

1.9

30.78

29.62

0.29

116

198

(40761536) Microorganisms panel - Urine sediment

1015

5775

1.86

67.24

5.7

4.3

—

(3009261) Glucose [Presence] in Urine by Test strip

4730

38956

1.49

67.00

5.6

4.3

0.01

0.31

estimate

0.98

1270

7844

(3024354) Oxygen [Partial pressure] in Venous blood

1253

7637

1.75

65.90

4.4

3.2

4.61

4.44

kpa

1.66

1207

7417

(4015189) Microbial culture of sputum

119

205

5.87

65.86

2.1

2.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

8.80

65.50

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

142

7.04

65.45

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1344

8382

1.72

65.04

5.1

3.8

—

(3006245) CD3-CD19+ cells/cells in Blood

120

211

5.76

65.01

2.0

1.9

9.34

11.81

0.94

109

190

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

32.46

65.01

1.0

14.73

15.38

mg/l

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1944

13372

1.59

63.80

4.6

3.4

1.81

2.06

e6/l

0.72

1014

6879

(3037756) Immunofixation for Serum or Plasma

469

2046

2.37

63.11

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3906

31192

1.47

63.06

5.8

4.4

93.02

76.60

ng/l

0.15

3221

24418

(3020891) Body temperature

773

4127

1.96

61.89

6.0

4.5

36.95

36.91

°c

3.70

761

4083

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

270

904

3.05

61.38

1.1

1.58

1.55

g/l

0.64

241

821

(3047181) Lactate [Moles/volume] in Blood

542

2559

2.20

60.39

10.5

5.7

1.40

1.33

mmol/l

0.96

497

2273

(3007853) Bacteria identified in Skin by Aerobe culture

1416

9127

1.66

60.08

2.2

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

406

1708

2.45

59.19

1.4

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

718

3800

1.97

58.85

8.8

5.1

0.86

0.87

0.35

682

3601

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

367

1491

2.53

57.65

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

568

2786

2.11

57.35

2.5

2.3

0.06

0.04

g/l

0.22

519

2485

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

551

2679

2.13

56.92

2.5

2.3

0.00

g/l

1.04

490

2326

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1361

8797

1.65

56.82

3.3

2.7

9.60

9.49

umol/l

0.06

1190

7749

(37208534) Antinuclear antibody arbitrary concentration in serum

102

177

5.82

56.05

1.0

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

114

7.25

55.78

1.1

1.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

642

3354

1.99

54.49

2.5

2.3

10.42

10.24

g/l

0.43

596

2927

(3015736) pH of Urine

3815

30912

1.43

53.74

4.5

3.8

6.24

6.25

0.25

1918

16855

(4035726) Immunohistochemistry procedure

1094

6794

1.70

52.89

1.5

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

343

1410

2.49

52.52

1.1

3.71

3.73

0.00

123

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

710

3886

1.90

52.47

2.4

2.3

3.87

3.73

g/l

1.44

668

3501

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

674

3630

1.93

52.28

2.5

2.3

3.11

2.91

g/l

6.11

635

3243

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2022

14564

1.51

52.24

4.3

3.3

1.00

1.11

e6/l

0.71

1106

8084

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

710

3895

1.90

52.09

2.4

2.3

7.83

7.42

g/l

7.94

671

3505

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

710

3895

1.90

52.09

2.4

2.3

4.13

4.18

g/l

0.92

672

3509

(3004809) Band form neutrophils/Leukocytes in Blood

350

1461

2.46

51.85

4.0

3.6

1.61

1.63

0.04

325

1281

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

511

2504

2.11

51.63

2.6

2.3

0.00

g/l

-0.00

489

2319

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

630

3338

1.96

51.26

2.6

2.3

0.64

0.99

g/l

1.90

554

2821

(3018572) Chloride [Moles/volume] in Blood

402

1807

2.29

50.35

11.4

6.6

103.91

105.01

mmol/l

4.59

369

1622

(3039000) Anion gap in Blood by calculation

402

1807

2.29

50.35

11.4

6.6

11.56

11.27

mmol/l

0.91

369

1621

(3018405) Lactate [Moles/volume] in Arterial blood

570

2939

2.01

50.11

5.0

3.9

1.43

1.41

mmol/l

0.17

560

2889

(3034426) Prothrombin time (PT)

175

5.54

50.10

1.1

1.2

26.92

29.03

3.10

175

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3115

24553

1.43

49.98

3.3

2.7

64.57

64.24

u/l

0.03

2927

22701

(3021788) Differential panel - Synovial fluid

347

1480

2.40

49.02

1.7

1.5

—

1.00

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

595

3138

1.96

49.01

7.4

4.1

25.00

24.79

mmol/l

1.01

562

2829

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

292

1161

2.57

47.95

7.9

6.3

12.26

12.19

mg/l

0.09

273

1068

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

391

1777

2.26

47.69

1.8

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

309

1267

2.49

47.57

1.3

1.2

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

8.67

44.30

1.1

1.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

910

5629

1.69

44.17

5.2

3.3

123.96

127.64

g/l

5.03

881

5458

(3024891) Influenza virus A+B Ag [Presence] in Specimen

352

1583

2.28

44.01

1.3

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

119

292

4.12

43.52

1.1

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

386

1817

2.18

43.16

1.2

112.83

128.66

titre

0.27

157

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

522

2778

1.94

41.74

1.5

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

451

2298

2.02

40.87

3.7

2.8

1.88

1.72

mg/l

3.24

418

2029

(3004451) EKG impression Narrative

163

518

3.19

40.56

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

378

1816

2.13

40.11

1.2

1128.67

903.85

titre

0.34

(3039744) RNA polymerase III Ab [Units/volume] in Serum

9.84

40.04

1.0

1.1

5.50

2.57

u/ml

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

5957

53462

1.39

39.48

44.1

23.7

14.36

13.86

114.31

5930

52700

(3041096) Erythrocytes [Presence] in Urine by Automated

2493

19514

1.39

39.15

5.3

3.8

0.11

0.34

estimate

1.29

1131

6335

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

200

728

2.79

39.13

1.1

4.63

3.21

0.31

(3003434) Protein [Mass/volume] in Pleural fluid

326

1497

2.23

38.75

1.5

32.04

31.14

g/l

0.59

285

1342

(3026008) Bacteria identified in Urine by Culture

3081

24995

1.37

38.74

4.0

3.6

—

(3000012) Reticulocyte production index

321

1465

2.24

38.73

2.6

2.1

0.97

0.88

1.81

251

1013

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

990

6459

1.60

38.64

5.4

3.9

114.17

97.14

ng/l

2.83

876

5474

(3023183) Ammonium ion [Moles/volume] in Plasma

370

1791

2.12

38.50

2.6

2.4

32.69

33.45

umol/l

0.25

352

1578

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

424

2173

2.00

37.77

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

243

995

2.49

37.54

1.5

1.4

6.63

6.33

mmol/l

0.76

226

919

(40768797) Stomach Pathology biopsy report

1448

10331

1.49

37.49

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

694

4179

1.72

36.92

5.2

3.5

25.52

25.09

mmol/l

2.15

661

4045

(3000060) B lymphocytes [#/volume] in Blood

139

5.29

36.40

2.0

1.9

0.76

1.21

e9/l

0.21

(3042111) Morphology [Interpretation] in Bone marrow Narrative

326

1544

2.16

35.88

1.7

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

229

4.18

35.63

1.1

18.25

5.09

u/ml

0.54

(3047007) Chlamydophila sp Ab [Presence] in Serum

194

731

2.69

35.54

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2142

16567

1.39

35.40

3.1

3.2

2.48

2.46

mmol/l

10.09

1952

14759

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

428

2260

1.94

34.96

1.6

1.4

—

(40768446) Kidney Pathology biopsy report

230

4.12

34.57

1.7

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

112

311

3.64

34.49

1.2

1.1

1.07

ratio

0.11

243

(3012441) Differential panel - Pleural fluid

256

1116

2.33

34.43

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

2454

19511

1.36

33.93

4.3

3.2

0.04

0.07

0.49

640

(3052851) Hemolysis interference index of Serum or Plasma

424

2264

1.92

33.49

4.5

3.5

2.76

1.98

index

1.15

243

1175

(3016650) Hepatitis A virus Ab [Presence] in Serum

234

996

2.39

33.24

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

122

5.36

32.95

1.5

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

176

4.52

32.80

2.5

2.6

1.76

2.02

ratio

0.52

157

(3008757) Leukocyte morphology finding [Identifier] in Blood

208

846

2.50

32.63

4.6

4.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

237

1025

2.35

32.48

1.4

1.3

410.16

412.36

u/l

0.01

224

972

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

188

732

2.60

32.30

1.6

1.4

14.11

13.40

u/l

0.58

180

704

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

245

3.87

31.74

1.5

2.0

197.80

170.76

1.51

232

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

245

1087

2.29

31.65

1.2

1.3

193.30

205.92

miu/ml

0.18

390

(3024928) Oxygen saturation in Venous blood

407

2197

1.90

31.09

4.7

2.9

64.31

59.95

3.46

394

2116

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

194

789

2.49

30.46

1.3

14.25

14.94

u/l

0.11

170

718

(3029937) Albumin [Presence] in Urine by Test strip

2696

22040

1.33

30.13

5.6

4.4

0.00

estimate

2.80

1203

7303

(3003327) Ova and parasites identified in Stool by Light microscopy

377

2008

1.92

30.00

1.8

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

147

525

2.83

29.89

1.9

8.19

8.10

mmol/l

0.09

147

525

(3010838) Calcium [Moles/time] in 24 hour Urine

257

1195

2.19

29.65

1.8

4.25

4.67

mmol/24h

1.33

232

1035

(40768806) Pleura Pathology biopsy report

242

1099

2.24

29.59

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1810

13973

1.38

29.35

1.3

1.27

1.78

u/ml

1.91

458

3511

(3003129) Base excess in Capillary blood by calculation

230

1033

2.26

28.89

3.3

2.4

0.80

0.34

mmol/l

1.06

223

990

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

173

687

2.55

28.58

1.8

1.7

4.53

4.64

mg/l

0.10

162

656

(3045142) Bone marrow Pathology biopsy report

219

977

2.27

27.96

1.5

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

428

2432

1.80

27.74

5.9

4.2

3.97

3.91

mmol/l

1.83

422

2407

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

188

790

2.41

27.53

1.2

64.38

66.79

u/l

0.18

167

683

(3040151) Glucose [Moles/volume] in Capillary blood

225

1028

2.22

27.14

9.9

13.7

7.53

7.39

mmol/l

0.21

199

844

(3045788) Cell count panel - Pleural fluid

228

1048

2.21

27.10

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

118

4.94

26.90

1.4

1.3

9375.00

4645.00

u/ml

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2916

24432

1.30

26.30

2.0

1.8

19.23

19.92

nmol/l

1.70

2561

20558

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

5.39

26.11

1.3

1.2

118.76

925.25

ng/l

0.49

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

189

817

2.34

26.00

1.1

7.00

20.52

au/ml

2.88

149

(3025941) Bacteria identified in Stool by Culture

556

3463

1.65

25.84

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

159

4.24

25.74

1.1

1.2

88.38

83.10

0.58

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1021

7279

1.46

25.73

3.1

2.5

44.85

45.71

u/l

0.03

903

6107

(3019309) Folate [Moles/volume] in Red Blood Cells

1992

15891

1.33

25.50

1.9

1.8

1175.92

1152.12

nmol/l

0.50

1539

11889

(3011397) Hemoglobin [Presence] in Urine by Test strip

2232

18148

1.31

24.86

4.8

4.0

0.11

0.40

0.60

225

(3000475) Leukocytes [#/volume] in Synovial fluid

368

2071

1.81

24.63

1.8

1.5

13276.93

14642.84

e6/l

0.21

266

1439

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

136

4.44

24.46

1.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

9.68

24.09

1.6

1.4

1.07

1.69

mg/l

0.28

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

542

3419

1.63

23.92

2.8

2.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

164

4.05

23.88

1.1

1.3

88.00

82.48

0.47

(3006571) Granulocytes/Leukocytes in Synovial fluid

205

952

2.18

23.79

1.7

1.5

58.09

62.26

0.77

125

620

(21494567) Legionella sp IgM Ab [Presence] in Serum

7.17

23.70

1.1

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

7.17

23.70

1.1

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

257

1306

2.00

23.49

1.5

3582.43

2968.59

e6/l

0.14

168

934

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

9.67

23.20

1.6

1.4

2.70

1.00

mg/l

0.62

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

9.67

23.20

1.6

1.4

3.44

2.50

mg/l

0.22

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

9.67

23.20

1.6

1.4

1.66

0.55

mg/l

0.61

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

9.67

23.20

1.6

1.4

1.23

2.67

mg/l

0.57

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

9.67

23.20

1.6

1.4

1.94

1.72

mg/l

0.05

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

9.67

23.20

1.6

1.4

1.80

1.52

mg/l

0.07

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

9.67

23.20

1.6

1.4

1.19

1.33

mg/l

0.08

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

9.67

23.20

1.6

1.4

2.11

0.99

mg/l

0.43

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

9.67

23.20

1.6

1.4

2.59

2.16

mg/l

0.12

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

5.02

22.74

1.7

1.5

92.81

146.76

au/ml

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

116

425

2.75

22.58

1.6

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

116

425

2.75

22.58

1.6

1.4

—

(3017354) Segmented neutrophils/Leukocytes in Blood

199

935

2.16

22.45

4.2

3.5

57.66

58.28

0.15

179

782

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

686

4637

1.52

22.38

5.4

4.2

45.08

46.41

0.70

674

4568

(3050794) Legionella sp Ab [Presence] in Serum

5.93

22.10

1.2

1.0

—

(40762365) Oxygen content in Arterial blood by calculation

148

4.08

21.95

2.2

2.8

15.07

14.67

ml/dl

0.38

139

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3289

28477

1.25

21.33

5.6

4.3

0.86

0.35

estimate

0.39

1174

6706

(3000093) Morphology [Interpretation] in Blood Narrative

181

839

2.18

21.15

1.3

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

214

1061

2.04

20.98

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

337

2.90

20.87

6.9

3.6

66.12

64.19

mg/l

0.09

231

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4724

42664

1.25

20.76

4.7

3.4

69.05

54.41

u/l

10.40

4448

39276

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

211

3.43

20.59

6.9

7.6

6.14

5.94

kpa

0.70

181

(21491868) Cryoglobulin [Mass/volume] in Serum

237

3.27

20.38

1.3

1.2

0.26

0.24

g/l

—

(3048689) Calprotectin [Mass/mass] in Stool

1036

7706

1.39

20.32

2.5

2.2

179.28

155.77

ug/g

1.17

861

6078

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

215

3.37

20.01

1.0

1.1

98.12

92.97

0.96

158

(3003329) Lymphocytes/Leukocytes in Synovial fluid

160

725

2.23

19.80

1.9

1.5

35.91

26.92

2.20

464

(3019230) Fractional oxyhemoglobin in Venous blood

316

1815

1.77

19.78

4.9

2.5

63.85

60.85

1.58

316

1806

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

871

6323

1.42

19.63

1.8

1.7

1.69

1.55

4.57

738

5350

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

372

2247

1.69

19.44

1.5

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

361

2166

1.70

19.34

3.5

3.3

0.86

0.81

nmol/l

1.12

292

1730

(3013005) Retinol [Moles/volume] in Serum or Plasma

240

3.19

19.32

2.6

1.6

1.94

umol/l

0.03

218

(3026389) Candida sp identified in Specimen by Organism specific culture

188

917

2.07

19.30

1.5

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

132

557

2.39

19.28

1.3

1.2

96.23

105.67

pmol/l

1.18

132

557

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.85

19.14

1.2

1.3

0.04

0.45

u/ml

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

223

1161

1.95

19.08

1.5

131420.83

50393.99

e6/l

1.27

115

678

(3000570) Elastase.pancreatic [Mass/mass] in Stool

389

2391

1.66

19.02

1.5

1.4

275.75

261.31

ug/g

0.33

239

1467

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

113

447

2.55

18.97

1.1

1.2

117.19

95.23

u/l

0.73

363

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

131

556

2.38

18.90

1.4

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

363

2.72

18.76

1.7

1.4

4.09

3.44

0.23

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3878

34503

1.23

18.73

3.8

2.9

—

estimate

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

171

3.59

18.69

1.7

1.6

8.65

9.90

ug/l

1.35

171

(3038071) Oxygen [Partial pressure] in Mixed venous blood

181

3.50

18.61

6.7

7.8

5.62

5.45

kpa

0.23

181

(40768795) Lymph node Pathology biopsy report

163

765

2.15

18.52

1.5

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

138

3.86

18.07

2.3

1.9

7.22

9.20

mg/l

1.70

113

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7020

66801

1.31

18.02

39.4

19.2

27.08

27.56

mg/l

0.66

6700

56694

(3035880) pH of Pleural fluid

130

563

2.33

17.94

1.4

1.3

7.38

7.41

0.71

385

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

109

437

2.51

17.82

1.1

1.2

45.45

26.18

u/l

1.05

351

(3019832) Treponema pallidum Ab [Presence] in Serum

430

2762

1.59

17.59

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

183

3.41

17.59

1.0

1.1

—

(3017704) Immunofixation for Urine

119

502

2.39

17.44

1.5

—

(40768804) Tissue Pathology biopsy report

3242

28452

1.23

17.42

2.5

2.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2056

17189

1.26

17.18

1.9

1.8

34240564.12

27830686.74

pmol/l

0.17

1691

13974

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

479

3171

1.54

17.16

2.4

1.9

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

4.55

16.53

2.2

2.8

103.63

35.89

mg/l

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

376

2.57

16.50

3.9

3.3

1.06

1.32

0.82

376

(3006576) Bicarbonate [Moles/volume] in Blood

282

2.82

16.27

7.8

6.4

25.24

24.75

mmol/l

0.40

252

(40768443) Skin Pathology biopsy report

520

3543

1.50

16.27

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

117

3.86

15.42

12.9

11.9

5.27

5.09

mmol/l

0.21

117

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

105

449

2.36

14.99

1.5

9.87

6.91

u/l

1.12

350

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

119

537

2.23

14.98

1.3

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

296

1821

1.65

14.49

1.3

—

(3013727) Leukocytes other/Leukocytes in Blood

269

2.73

14.22

4.0

3.6

59.38

54.48

1.10

257

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

815

6168

1.36

14.13

3.8

2.8

55.20

61.72

ml/min/173m2

5.70

427

2691

(3044927) Protein electrophoresis panel - Urine

178

955

1.88

14.02

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.20

13.88

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

131

3.53

13.85

1.2

18.67

104.78

titre

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

110

3.74

13.48

1.1

1.3

88.60

76.50

0.72

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

110

3.74

13.48

1.1

1.3

78.14

77.86

0.01

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

158

829

1.92

13.34

2.8

3.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

999

7851

1.31

13.33

2.9

2.4

10.22

7.05

ug/l

3.97

884

6777

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

436

2.29

13.26

1.2

1.1

30.41

26.87

u/l

0.27

384

(3020682) Albumin/Creatinine [Ratio] in Urine

3097

27562

1.20

13.26

5.0

4.2

14.92

9.34

mg/mmol

4.95

2066

17472

(3009508) Creatinine [Moles/volume] in Urine

3095

27543

1.20

13.25

4.1

3.4

6.92

7.34

mmol/l

7.53

2610

22841

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

156

819

1.92

13.15

1.2

1.1

1.10

1.76

u/ml

0.69

469

(3010726) Horse dander IgE Ab [Units/volume] in Serum

124

600

2.08

13.15

1.1

1.19

1.11

u/ml

0.05

323

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

110

509

2.18

13.08

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

177

3.06

13.02

1.6

1.5

0.33

0.39

ug/l

0.65

106

(3006922) Hepatitis E virus Ab [Presence] in Serum

104

472

2.22

12.98

1.0

1.1

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

312

2.51

12.94

1.5

2.37

0.00

265

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

441

2.26

12.92

1.2

1.1

88.08

84.29

u/l

0.18

390

(3023383) Lactate [Moles/volume] in Pleural fluid

319

2.49

12.85

1.3

3.66

3.32

mmol/l

0.38

290

(3023430) Cat dander IgE Ab [Units/volume] in Serum

106

487

2.19

12.84

1.1

1.49

3.39

u/ml

1.41

220

(3014133) Dog dander IgE Ab [Units/volume] in Serum

111

520

2.15

12.81

1.1

2.42

2.84

u/ml

0.18

264

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

381

2.35

12.74

1.4

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

2823

25004

1.19

12.55

3.5

2.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

722

9381

0.75

12.18

10.8

8.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

117

571

2.06

12.16

1.6

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

223

2.75

12.12

1.9

2.0

62.09

36.78

u/l

0.46

208

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

378

2.32

12.07

1.5

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

118

581

2.05

11.98

1.6

1.3

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

370

2.31

11.75

1.4

1.5

65.82

67.72

0.17

305

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.91

11.71

1.3

1.1

0.88

1.14

iu/ml

0.44

(3020876) Protein [Mass/time] in 24 hour Urine

199

1168

1.72

11.70

2.3

1.08

1.18

g/24h

0.26

132

666

(44816559) Phosphatidylethanol [Mass/volume] in Blood

357

2412

1.50

11.69

1.7

1.5

0.36

0.31

mg/l

0.72

170

1075

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3944

36101

1.17

11.59

2.4

2.3

92.47

94.00

pmol/l

1.23

2229

19455

(3041918) Cholesterol [Moles/volume] in Pleural fluid

201

2.80

11.54

1.2

1.95

1.44

mmol/l

1.10

129

(3051611) Lipemic interference index of Serum or Plasma

151

821

1.85

11.50

5.4

3.4

14.14

12.82

index

0.83

113

438

(3045424) Erythrocytes [Presence] in Urine

531

3879

1.39

11.45

2.5

2.2

0.08

0.24

estimate

0.28

166

1068

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

277

2.50

11.41

2.7

2.5

0.62

mmol/l

0.09

277

(3012516) Albumin [Mass/volume] in Urine

3005

26924

1.18

11.40

4.1

3.5

75.42

51.76

mg/l

4.75

2084

17648

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

130

3.24

11.18

2.8

3.4

6.49

7.93

mg/l

0.57

105

(3012565) Volume of 24 hour Urine

354

2.30

11.12

2.1

2.3

1673.56

1838.91

0.95

299

(3003888) Timothy IgE Ab [Units/volume] in Serum

129

674

1.93

11.11

1.1

2.70

3.44

u/ml

0.32

345

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.71

11.09

1.2

1.3

214293.54

350006.96

nmol/l

0.16

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

288

2.44

11.00

1.2

1.1

10.82

22.03

u/ml

—

108

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

159

2.97

10.79

1.2

—

(3011544) Albumin [Mass/volume] in Pleural fluid

104

3.47

10.68

1.2

1.1

16.43

17.36

g/l

0.31

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.13

10.59

1.3

1.7

—

(36660697) Celiac disease serology panel - Serum

649

4958

1.33

10.54

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

166

959

1.75

10.38

1.8

2.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

8.77

10.24

1.2

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

143

3.02

10.19

1.2

—

580.00

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

514

3809

1.37

10.18

3.1

3.3

4.20

4.38

pmol/l

3.23

455

3353

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

155

2.91

10.04

1.4

1.5

5.76

11.66

1.57

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

436

2.10

10.01

1.1

0.20

u/ml

0.01

174

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

253

2.46

9.96

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

218

2.58

9.92

1.2

—

(21494434) Karyotype in Bone marrow

141

788

1.80

9.89

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

256

1676

1.54

9.77

1.5

1.4

62.93

61.40

mmol/l

0.25

227

1348

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

142

2.97

9.69

7.0

7.1

10.25

10.37

0.12

142

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.67

9.68

1.7

1.6

—

(3016750) Collection duration of Urine

443

2.07

9.62

2.1

475.26

496.24

min

0.96

312

(3008401) Mugwort IgE Ab [Units/volume] in Serum

122

658

1.87

9.60

1.1

0.67

1.02

u/ml

0.49

300

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

398

2.12

9.54

1.8

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

398

2.12

9.54

1.7

1.4

—

(3022145) Colonoscopy Study observation

1034

8499

1.25

9.46

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

161

2.80

9.39

1.2

0.45

1.73

mmol/l

1.56

108

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5411

51215

1.16

9.19

4.6

4.3

15.03

pmol/l

0.02

4976

46194

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

201

1263

1.61

9.18

1.6

1.9

22.16

24.00

ug/l

0.20

195

1232

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

135

764

1.78

9.12

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2157

19082

1.18

9.08

3.4

2.5

—

(3037121) Protein [Mass/volume] in Urine

394

2851

1.40

9.04

3.1

420.70

465.22

mg/l

0.23

207

1276

(3026051) Granulocytes/Leukocytes in Pleural fluid

242

2.41

8.92

1.3

1.4

25.75

22.63

0.30

203

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

9.46

8.75

1.3

0.57

0.29

iu/ml

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

425

3136

1.37

8.68

1.1

0.88

1.18

u/ml

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.24

8.64

1.2

3284.50

2879.62

ng/l

0.10

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

304

4284

0.70

8.53

2.3

2.1

3.67

3.44

ratio

0.48

248

3424

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

128

730

1.77

8.45

1.3

—

(44806071) Cardiolipin IgM antibody measurement

3.56

8.38

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

232

2.38

8.29

1.1

14.30

1.84

u/ml

1.13

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

113

3.02

8.13

2.4

2.8

156.48

140.24

au/ml

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.38

8.05

2.4

1.5

45.89

45.43

umol/l

0.03

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

563

4388

1.30

7.95

2.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.52

7.95

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.52

7.95

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.52

7.95

1.4

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

143

2.74

7.84

1.2

1.3

214.91

278.97

u/l

0.09

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

942

7821

1.23

7.81

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

154

947

1.64

7.75

1.7

1.4

—

(44813793) Dust mix specific IgE antibody measurement

357

2.05

7.71

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

191

2.47

7.70

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

207

3071

0.67

7.67

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

154

950

1.63

7.66

1.7

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

374

2.01

7.53

1.0

1.1

8.56

10.30

iu/ml

0.27

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

3.30

7.50

1.2

1.0

10.87

17.72

iu/ml

0.49

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

419

1.94

7.34

2.3

1.9

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

4.14

7.26

1.8

2.0

1.21

1.44

mg/l

0.51

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

110

2.92

7.25

1.4

72.79

73.55

0.04

(3025468) Yersinia sp identified in Specimen by Organism specific culture

151

944

1.61

7.15

1.7

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

7.91

7.09

1.7

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

262

1846

1.43

7.07

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

263

1855

1.43

7.05

1.3

1.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

209

3040

0.68

7.02

2.0

1.8

3.35

3.39

mmol/l

0.21

154

2182

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.15

6.97

1.0

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

347

2.00

6.80

1.2

—

(3020491) Glucose [Moles/volume] in Blood

518

1.80

6.74

2.1

2.0

7.54

7.00

mmol/l

1.07

353

(44786800) Granulocytes/Leukocytes in Body fluid

115

2.79

6.72

1.2

1.3

20.99

21.48

0.02

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

258

1832

1.42

6.69

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

186

2.37

6.67

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

448

1.86

6.66

1.7

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.71

6.62

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

156

1002

1.57

6.62

1.7

1.4

—

(3036525) Urea [Moles/time] in 24 hour Urine

4.01

6.61

3.7

3.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

210

1438

1.47

6.61

1.1

15.03

7.14

eliau/ml

0.60

117

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

139

2.60

6.60

1.4

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

154

988

1.57

6.57

1.7

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

778

9328

0.82

6.57

5.2

5.3

32.58

33.16

0.76

564

6017

(3007919) Fasciola sp Ab [Titer] in Serum

10.01

6.52

1.2

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1074

9207

1.19

6.36

3.4

4.2

19.53

27.73

ug/l

0.47

909

7673

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

281

2.07

6.35

7.0

2.4

4.77

4.86

kpa

0.31

281

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.05

6.34

1.7

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

499

1.79

6.34

2.0

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

152

981

1.56

6.34

1.8

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

282

2.06

6.30

7.0

2.4

9.21

10.12

kpa

2.28

282

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

223

1569

1.43

6.12

1.2

1.3

47.05

35.10

u/l

0.43

196

1343

(3020961) Endomysium IgA Ab [Titer] in Serum

354

2687

1.33

6.11

1.1

333.13

157.48

titre

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

7.23

5.91

1.1

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2362

25762

0.88

5.88

4.4

5.0

22.19

22.32

0.14

1112

13926

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

3.11

5.87

3.9

2.7

0.81

1.21

mg/l

1.41

(3020393) Adenovirus Ag [Presence] in Stool

3.19

5.85

1.2

1.0

—

(3004775) Volume in Urine collected for unspecified duration

107

650

1.65

5.76

2.3

2.2

577.37

651.35

1.24

405

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.17

5.69

6.0

11.0

109.69

104.97

g/l

0.62

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

164

2.32

5.56

1.3

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

483

1.75

5.55

1.0

297.21

286.46

mg/l

0.68

439

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

304

1.95

5.51

1.4

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

114

714

1.60

5.46

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

336

1.88

5.33

1.3

68.74

419.61

ug/l

1.61

169

(3035320) C reactive protein [Mass/volume] in Body fluid

580

1.66

5.31

3.1

2.8

33.39

33.24

mg/l

0.01

437

(3008295) Osmolality of Serum or Plasma

140

926

1.52

5.30

1.4

1.3

271.76

276.99

mosm/kgh2o

1.85

120

686

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

295

1.94

5.27

4.1

1.6

184.12

111.27

umol/l

0.57

167

(3003740) Influenza virus B Ag [Presence] in Specimen

113

715

1.59

5.21

1.2

1.1

—

(3024263) Appearance of Synovial fluid

412

1.78

5.17

2.0

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

422

1.76

5.06

1.5

1.3

1.34

1.21

nmol/l

0.39

300

(3010144) Erythrocytes [#/volume] in Synovial fluid

123

802

1.54

4.99

1.7

1.3

89935.01

155351.98

e6/l

0.69

532

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.16

4.75

1.2

0.10

0.07

g/l

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

319

2479

1.30

4.73

1.3

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

286

1.89

4.71

1.6

1.5

24.14

18.22

0.76

260

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

272

1.92

4.70

1.1

1460.95

1585.67

miu/ml

0.32

272

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.49

4.60

1.1

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.82

4.49

1.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.41

4.46

1.5

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

188

2.08

4.44

1.7

1.4

0.40

0.32

mmol/l

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.80

4.43

4.5

4.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

518

1.63

4.37

1.3

1.11

1.14

promille

0.07

414

(3030981) Hyaline casts [#/volume] in Urine by Automated count

835

7234

1.17

4.37

3.6

2.6

0.45

0.48

e6/l

0.12

808

6985

(3020717) Zinc [Moles/volume] in Serum or Plasma

345

1.77

4.35

2.1

1.4

18.83

21.43

umol/l

0.30

318

(40765096) Chromosome analysis panel by Banding

267

1.88

4.29

1.2

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1122

0.60

4.25

1.1

0.63

0.64

ratio

0.03

193

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

104

681

1.53

4.21

2.2

2.0

3789.34

3793.61

u/l

0.00

278

(3016135) IgD [Mass/volume] in Serum

8.01

4.05

1.3

329.75

39.25

mg/l

—

(3006969) Lambda light chains [Mass/volume] in Urine

4.62

4.05

1.0

0.21

0.12

g/l

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.20

4.05

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

421

1.67

4.04

2.4

2.6

24.13

42.59

umol/l

—

(3003694) ABO and Rh group [Type] in Blood

2015

18579

1.11

4.04

1.5

1.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.45

4.04

1.3

1.9

94.80

39.56

pmol/l

0.55

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.07

3.89

1.4

—

(3008898) HLA-B27 [Presence]

204

1537

1.34

3.85

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

172

2.04

3.83

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

107

721

1.49

3.82

1.3

1.4

—

(3044007) Cell count panel - Peritoneal fluid

264

1.82

3.80

1.9

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

102

2.36

3.73

1.2

22.07

20.00

u/l

0.17

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.40

3.61

1.3

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.54

3.45

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1244

0.66

3.45

1.1

1.2

1.53

1.52

g/l

0.12

1244

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1735

18767

0.90

3.39

3.2

3.5

0.74

0.82

ug/l

2.89

1252

13390

(3036670) Protein [Mass/volume] in Synovial fluid

276

1.74

3.32

1.3

1.2

33.07

40.89

g/l

3.26

130

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

155

2.00

3.28

1.2

186.44

31.94

mg/l

0.38

113

(40758292) HTLV I+II Ab panel - Serum

115

2.18

3.27

1.3

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

3.34

3.21

2.2

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

136

2.06

3.21

1.1

1085.71

861.11

titre

—

(3016038) Potassium [Moles/volume] in Urine

594

1.49

3.19

1.3

1.1

34.35

34.82

mmol/l

0.08

502

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.80

3.18

2.5

5.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

470

3994

1.19

3.17

1.3

52.13

58.08

au/ml

0.21

273

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

2.73

3.15

1.3

0.82

0.92

ml/s/173m2

—

(40768441) Liver Pathology biopsy report

515

1.52

3.14

1.5

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.50

3.11

1.2

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

366

1.62

3.11

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

194

1.86

3.09

1.3

0.34

0.30

g/l

1.56

158

(3045414) Leukocytes [Presence] in Urine

852

7592

1.14

3.06

2.6

2.2

0.01

estimate

0.00

206

1427

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.58

3.04

1.2

—

mmol/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1171

0.68

3.00

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

420

3553

1.19

3.00

1.2

120.49

127.59

u/ml

0.15

134

1237

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

508

4370

1.17

2.98

2.4

2.5

31.14

22.36

au/ml

0.82

356

(3019550) Sodium [Moles/volume] in Serum or Plasma

7042

69222

1.11

2.98

42.3

23.6

139.06

139.62

mmol/l

55.41

6986

67843

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

100

703

1.43

2.96

1.8

2.0

1.21

1.34

u/field

0.17

380

(3028707) Methadone [Presence] in Urine by Screen method

426

1.55

2.96

2.3

2.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

162

1.92

2.93

1.6

1.2

17.10

16.04

umol/l

0.53

147

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

104

738

1.41

2.93

1.5

1.6

17.93

26.58

u/ml

1.09

151

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

6.67

2.86

1.2

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

398

1.56

2.86

1.7

1.8

1.62

2.71

u/field

0.81

268

(3001729) Color of Synovial fluid

2.40

2.79

2.4

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

330

1.61

2.79

1.6

1.5

9.38

10.88

ug/l

0.19

296

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

129

959

1.35

2.77

1.2

1.3

296.34

290.95

pmol/l

0.06

112

791

(3043410) Blood group antigens tested for on Red Blood Cells

225

1.74

2.73

2.6

1.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

129

964

1.34

2.69

1.1

61.38

245.85

iu/ml

0.51

183

(3023511) Choriogonadotropin [Units/volume] in Urine

287

1.64

2.68

1.5

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

182

1.82

2.68

1.2

1.3

111.04

110.00

0.07

161

(4212803) Bone marrow aspirate examination

2.28

2.67

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

2007

21352

0.92

2.65

3.7

3.6

—

(3044009) aPTT.lupus sensitive (LA screen)

2.79

2.64

1.4

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

7043

69318

1.10

2.64

42.8

23.8

4.02

4.00

mmol/l

7.15

6980

67836

(3005011) Chlamydia sp Ab [Titer] in Serum

2.39

2.62

1.4

1.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

136

1775

0.76

2.56

1.7

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.46

2.54

1.2

2.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

101

2.08

2.52

1.0

1.1

14.95

8.83

u/ml

0.37

(3002331) Protein [Mass/volume] in Peritoneal fluid

209

1.73

2.49

1.4

186.15

27.24

g/l

0.48

165

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

4.38

2.47

1.0

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

4.38

2.47

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

294

1.60

2.46

1.2

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

203

1.73

2.43

1.3

34.90

34.99

0.01

137

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.24

2.43

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

272

1.62

2.42

1.0

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

189

1.75

2.40

2.1

1.7

118.11

110.69

ug/l

0.15

162

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

284

2373

1.20

2.39

1.6

32.79

23.08

u/ml

0.38

440

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

3.34

2.39

1.1

1.0

—

(40763791) Oxygen content in Venous blood by calculation

4.12

2.36

7.7

2.9

12.63

11.94

ml/dl

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.61

2.35

1.0

1.1

88.00

94.61

titre

0.12

(3012494) Peanut IgE Ab [Units/volume] in Serum

104

2.02

2.35

1.0

1.1

0.94

41.34

u/ml

0.49

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

176

1401

1.26

2.34

2.9

1.6

1.12

0.84

nmol/l

4.18

144

1167

(4027681) Cerebrospinal fluid IgG ratio and IgG index

293

1.57

2.26

1.2

2.11

0.53

ratio

0.50

172

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

406

1.48

2.25

3.0

2.9

232.97

205.03

u/l

1.49

399

(3002814) Trichinella spiralis Ab [Titer] in Serum

5.56

2.21

1.0

1.1

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

2.19

2.20

2.8

1.8

66.80

66.35

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

115

876

1.32

2.17

1.4

1.3

0.18

0.21

nmol/l

0.63

718

(3038177) Helicobacter pylori Ab [Presence] in Serum

114

868

1.32

2.16

1.2

1.3

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.69

2.15

7.9

6.0

391.86

369.00

umol/l

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.69

2.15

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

101

1.98

2.15

1.5

1.3

102.38

103.86

ug/l

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

138

1080

1.28

2.14

2.9

2.1

27.60

25.32

mg/l

0.19

366

(3034274) Bile acid [Moles/volume] in Serum --fasting

355

1.50

2.11

1.1

1.6

6.18

10.64

umol/l

1.51

252

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

127

986

1.29

2.10

1.5

1.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

323

1.52

2.10

6.0

5.5

44.38

668.50

u/ml

—

(3032057) Clostridioides difficile [Presence] in Stool

190

1.69

2.09

2.3

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

308

1.53

2.07

2.0

2.1

550.67

3268.86

e6/l

0.55

214

(1001926) Buprenorphine [Presence] in Urine by Screen method

736

1.34

2.06

1.9

1.8

—

(3019150) Specific gravity of Urine by Refractometry

1820

17176

1.08

2.06

5.5

4.6

2.51

1.10

kg/l

0.73

1351

11754

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.18

2.04

1.4

1.1

1.76

1.74

umol/24h

0.03

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

207

1.65

2.03

1.6

1.4

21.29

16.19

pmol/l

0.55

165

(3016244) Insulin [Units/volume] in Serum or Plasma

246

1.59

2.03

2.7

2.8

10.46

20.46

mu/l

5.03

232

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

635

1.36

2.02

1.3

1.4

128.57

326.67

titre

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6297

61878

1.07

1.99

5.8

5.3

2.07

2.02

mu/l

1.24

5836

56205

(3011985) Renin [Units/volume] in Plasma

131

1032

1.27

1.96

1.3

1.4

48.41

63.72

mu/l

0.61

119

913

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

561

0.64

1.95

1.6

1143.64

993.88

mu/l

0.34

453

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

104

795

1.31

1.95

1.4

1.3

1.55

1.47

nmol/l

0.29

707

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

597

0.65

1.95

1.1

1.0

345.00

321.63

ng/l

0.18

408

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.35

1.94

1.0

1.1

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

2.19

1.94

2.3

1.7

5.29

12.92

—

(3008037) Lactate [Moles/volume] in Venous blood

275

2346

1.18

1.90

4.7

3.4

1.65

mmol/l

0.00

267

2278

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

106

1.89

1.90

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.00

1.89

1.8

1.2

22.34

20.71

mmol/l

0.60

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.31

1.87

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

601

0.66

1.85

1.1

1.0

38.60

42.07

ng/l

0.20

405

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

126

997

1.27

1.84

1.4

1.3

7.51

3.89

nmol/l

0.21

117

959

(3027008) Opiates [Presence] in Urine

120

944

1.28

1.84

1.8

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

237

1.56

1.83

1.4

1.5

16.42

13.60

g/l

1.13

179

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

190

1.63

1.83

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

599

0.67

1.82

1.1

1.0

804.00

698.87

ng/l

0.92

401

(3052592) Norovirus Ag [Presence] in Stool

175

1.66

1.82

1.8

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1038

0.75

1.79

1.5

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

6480

63810

1.07

1.79

34.2

19.3

72.48

74.11

ml/min/173m2

7.67

6221

59699

(3023323) Follitropin [Units/volume] in Serum or Plasma

174

1433

1.22

1.78

1.5

1.4

32.67

30.39

iu/l

0.36

138

1218

(3028300) Cannabinoids [Presence] in Urine

120

949

1.27

1.77

1.8

—

(40768800) Prostate Pathology biopsy report

184

2210

0.83

1.77

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

651

1.32

1.76

1.0

1.1

12.63

3.34

eliau/ml

0.77

228

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

264

1.52

1.75

1.8

1.9

17057.58

14690.89

e6/l

0.07

143

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.33

1.74

1.0

1.1

0.01

0.03

u/ml

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.98

1.74

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

147

1.70

1.73

1.2

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

170

1.65

1.73

1.3

1.2

268.94

279.58

pmol/l

0.06

125

(3016879) Cocaine [Presence] in Urine

111

873

1.28

1.72

1.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

221

1870

1.19

1.71

3.2

3.3

298.96

899.68

u/ml

1.71

198

1710

(3011288) Drugs identified in Urine by Screen method Nominal

628

1.32

1.71

5.7

2.5

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

3.85

1.71

1.0

—

(3041184) Isoniazid [Presence] in Urine

3.85

1.71

2.6

2.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.06

1.70

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

362

3189

1.14

1.67

3.0

3.4

7344.49

1499.76

u/ml

0.38

305

2749

(3016018) Differential panel - Cerebral spinal fluid

762

1.29

1.67

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

159

1308

1.22

1.67

1.5

1.4

11.37

10.63

u/l

0.25

131

1040

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.18

1.67

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.50

1.66

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

285

1.48

1.63

2.4

2.3

39.85

56.10

umol/l

1.84

246

(3027944) Amphetamines [Presence] in Urine

117

934

1.26

1.62

1.8

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6326

64179

0.94

1.61

5.6

5.4

1.39

1.43

mmol/l

8.67

5741

58493

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

129

1.71

1.56

1.3

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6380

64689

0.94

1.55

5.7

5.5

4.32

4.43

mmol/l

13.37

5828

59404

(3049717) Cytology report of Urine Cyto stain

435

3898

1.12

1.55

2.8

2.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

372

0.62

1.53

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

117

942

1.25

1.53

1.9

1.8

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

121

978

1.24

1.53

3.3

3.7

24.23

34.33

u/ml

1.45

115

951

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

162

1.61

1.48

1.2

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.43

1.47

3.0

2.5

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

228

1.49

1.43

1.4

1.2

17.49

11.65

pmol/l

0.45

(3002256) Pathology report gross observation

1095

10293

1.07

1.41

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

111

1.71

1.38

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.08

1.38

1.1

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

398

1.36

1.38

1.1

279.21

306.34

mg/l

0.50

346

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

312

0.61

1.37

1.5

1.4

1.62

1.14

ratio

—

192

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

312

0.61

1.37

1.5

1.4

0.94

0.95

ratio

—

192

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

312

0.61

1.37

1.5

1.4

1.30

1.23

ratio

—

192

(3014891) Appearance of Pleural fluid

150

1.60

1.37

1.7

1.4

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

2.61

1.36

2.3

2.30

2.96

mg/l

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.94

1.36

11.0

8.2

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

323

1.40

1.35

1.2

1.3

60.67

62.85

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6528

66069

0.95

1.34

6.4

6.3

2.44

2.54

mmol/l

17.29

5962

60458

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

310

0.61

1.34

1.5

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

273

1.43

1.34

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.34

0.0

1.1

—

(3019174) dRVVT (LA screen)

2.13

1.33

1.4

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

421

4649

0.90

1.32

1.2

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

384

1.36

1.32

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

124

1026

1.21

1.30

1.4

1.3

0.14

0.27

nmol/l

2.16

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

413

1.33

1.27

1.8

1.7

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.29

1.26

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

626

1.26

1.24

1.1

—

57.63

—

(3038515) Glucose [Moles/volume] in Venous blood

228

1996

1.15

1.23

5.1

3.6

7.63

7.70

mmol/l

0.15

221

1941

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6454

63765

1.05

1.21

8.1

7.3

41.15

40.29

mmol/mol

10.26

6049

58733

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.63

1.21

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

337

0.65

1.21

1.5

66.71

60.82

ug/l

0.10

273

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

226

1981

1.14

1.20

2.5

2.3

149.38

111.30

ug/min

0.55

137

1134

(3017315) Amylase [Enzymatic activity/volume] in Urine

365

1.34

1.20

1.1

1.2

230.88

290.08

u/l

0.55

330

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

419

1.31

1.17

1.1

49.29

44.83

mg/l

0.29

348

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.93

1.16

1.3

1.8

1.36

1.45

umol/l

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.93

1.16

2.8

4.0

48.68

55.97

mg/mmol

0.12

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

198

1727

1.15

1.3

684.52

586.57

mg/l

0.31

183

1639

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.81

1.14

1.2

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.73

1.14

2.1

2.7

0.60

0.45

u/field

0.24

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

189

1645

1.15

1.13

1.9

1.8

8.75

7.71

iu/l

0.06

596

(40768793) Breast Pathology biopsy report

159

1367

1.17

1.12

1.4

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.33

1.12

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

448

0.71

1.12

1.8

344.48

352.88

mu/l

0.06

353

(3020650) Glucose [Presence] in Urine

225

1.42

1.11

1.9

1.7

0.00

0.05

estimate

1.34

225

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

103

854

1.21

1.10

1.5

1.3

—

nmol/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3121

32030

0.96

1.10

5.3

6.1

3.14

3.70

ug/l

0.50

2749

28681

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

446

0.72

1.09

1.0

1.1

5.18

12.06

nmol/l

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.38

1.09

1.2

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.19

1.08

1.0

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

279

0.64

1.07

1.4

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

330

1.34

1.06

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

153

1.50

1.06

1.4

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

211

1.42

1.05

1.1

1.2

19.00

30.83

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

562

1.25

1.02

1.3

2.27

2.22

mmol/l

0.12

527

(3032868) Hemoglobin electrophoresis panel in Blood

1.92

1.02

1.3

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.00

1.00

1.0

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

369

1.30

0.99

1.0

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

174

1527

1.14

0.96

1.2

3.91

3.83

mmol/l

0.33

161

1436

(37021550) Renin [Units/volume] in Plasma --upright

165

1.46

0.96

1.3

83.42

69.82

mu/l

0.19

120

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

108

1.58

0.96

1.9

1.7

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

5218

52921

0.96

0.95

46.1

25.2

329.08

331.59

g/l

70.62

5190

52556

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7008

69501

1.05

0.94

23.5

13.0

25.17

25.55

u/l

0.95

6930

67085

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

117

1.54

0.93

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

269

0.67

0.93

1.5

—

(3025577) Chromium [Mass/volume] in Blood

553

1.23

0.91

2.0

2.1

1.50

2.17

ug/l

2.96

456

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

169

1489

1.14

0.90

1.2

1.4

65.03

27.97

e6/l

0.40

117

1098

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

193

1.40

0.90

2.3

2.4

11.01

222.29

ug/l

0.79

193

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

243

0.66

0.90

1.7

1.8

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

143

1.47

0.89

1.2

1.1

0.78

0.66

umol/24h

0.46

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.07

0.89

1.3

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

601

1.22

0.88

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

430

1.26

0.88

2.4

2.1

78.70

177.31

ug/min

—

112

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

361

1.28

0.85

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

170

1507

1.13

0.84

1.3

1.4

505.05

1038.74

e6/l

0.79

128

1188

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.56

0.84

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.56

0.84

1.1

1.0

21.77

41.29

iu/ml

1.80

(3020911) Cortisol [Moles/time] in 24 hour Urine

213

1.36

0.84

1.5

1.4

97.76

371.56

nmol/24h

1.17

213

(4198724) Urine methamphetamine measurement

137

1.46

0.83

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

318

1.29

0.83

1.7

8.39

7.34

nmol/l

0.07

272

(3047352) Trisomy 18 risk [Likelihood] in Fetus

259

0.69

0.79

1.4

1.5

—

(44806420) Estimation of glomerular filtration rate

608

0.80

0.79

2.8

2.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

103

888

1.16

0.77

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

225

1.33

0.77

1.1

1.3

114.60

139.79

nmol/l

0.52

167

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

225

1.33

0.77

1.1

—

(3005033) Fetal Nuchal fold Thickness US

257

0.70

0.76

1.4

1.21

1.27

—

177

(3000330) Specific gravity of Urine by Test strip

401

4301

0.93

0.75

4.6

3.7

1.02

ratio

1.16

377

3903

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

302

0.73

0.75

1.1

738.44

502.30

ng/l

—

(3023410) Appearance of Cerebral spinal fluid

632

1.19

0.75

1.3

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

201

2221

0.90

0.74

5.5

4.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

116

1324

0.87

0.74

2.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.84

0.73

9.9

9.3

—

(40758358) Immune stain study

2.00

0.72

1.0

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

100

1.50

0.72

1.1

1.5

509.27

386.01

mu/l

0.38

(3028717) Thiamine [Mass/volume] in Blood

100

1.50

0.72

1.2

58.80

64.97

ug/l

0.68

100

(4034850) Laboratory test

241

2203

1.10

0.72

16.0

11.9

—

(3026726) Creatinine [Moles/volume] in Specimen

1.58

0.71

3.1

2.6

399.08

495.58

umol/l

0.11

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

168

1.37

0.71

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.58

0.71

1.1

5.6

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.92

0.70

1.0

0.07

0.12

u/ml

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

300

1.27

0.70

1.1

1.12

1.18

u/l

0.30

141

(3021387) Prolactin [Units/volume] in Serum or Plasma

137

1219

1.13

0.68

1.4

1.8

316.60

302.93

mu/l

0.20

122

1126

(3020874) Milk IgE Ab [Units/volume] in Serum

213

1.32

0.68

1.0

1.1

0.79

1.42

u/ml

0.58

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

192

0.68

0.67

1.5

1.6

61.91

53.97

ug/l

0.31

192

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.63

0.66

1.0

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

560

1.18

0.64

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.52

0.62

1.4

1.3

—

609.28

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1091

0.88

0.61

1.8

1.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

183

1.31

0.59

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

183

1.31

0.59

1.4

1.1

—

(1002224) Polysomnography panel

244

2259

1.08

0.58

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.51

0.58

2.1

2.3

—

(3051101) Glucose [Moles/volume] in Cord blood

162

0.68

0.58

6.8

6.4

8.73

8.53

mmol/l

0.13

162

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.46

0.57

2.4

3.0

36.46

86.20

pmol/l

2.53

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.56

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.45

0.56

1.0

1.1

0.02

0.03

u/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

149

1359

1.10

0.52

1.4

1.3

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

100

1.40

0.51

1.1

1.5

76.86

73.25

0.58

(3006442) Creatine [Moles/volume] in Serum or Plasma

453

1.17

0.50

2.0

1.7

91.68

91.86

umol/l

0.01

453

(3025130) Human papilloma virus identified in Specimen

547

1.15

0.50

1.8

1.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.52

0.48

4.7

3.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

253

1.23

0.48

1.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.49

0.47

3.6

4.6

—

0.00

estimate

—

(4024509) Urine culture

357

3757

0.95

0.44

2.2

2.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.37

0.44

1.1

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

247

1.22

0.44

28.2

19.5

1419.30

1356.17

nmol/l

0.21

237

(4281824) Cell count and differential, peritoneal fluid

715

1.12

0.43

1.1

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

317

0.82

0.42

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

331

1.18

0.42

1.3

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

1.43

0.42

1.9

1.8

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.52

0.41

1.0

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.47

0.40

1.4

1.46

3.74

nmol/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

195

1.23

0.40

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6120

61554

0.98

0.39

4.8

4.6

1.34

1.27

mmol/l

11.11

5499

55391

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

363

1.16

0.38

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

197

1.22

0.37

1.2

1.3

22.33

11.96

mm/h

1.52

197

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.30

0.37

1.0

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.39

0.36

13.0

12.6

0.56

0.24

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2751

27865

0.98

0.36

2.2

2.0

1.40

1.32

mmol/l

5.64

2254

22901

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

189

1.22

0.36

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

235

1.19

0.36

20.7

14.5

822.79

801.63

nmol/l

0.08

222

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.40

0.35

1.0

—

(3006462) Nitrate [Presence] in Urine

348

1.15

0.34

5.3

3.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.33

0.33

1.8

1.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

200

1.20

0.33

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

100

1.30

0.33

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

393

0.86

0.33

1.5

1.4

138.89

185.52

pmol/l

0.96

393

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.30

0.33

1.5

1.4

415.83

332.35

umol/24h

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

7079

70532

1.02

0.32

45.7

25.9

91.59

84.15

umol/l

23.21

7026

69532

(3014271) Vancomycin [Susceptibility]

512

1.11

0.31

3.0

2.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

302

2894

1.05

0.31

1.7

1.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

504

1.11

0.30

3.7

5.7

93.00

65.64

u/ml

0.26

163

(3015076) Soybean IgE Ab [Units/volume] in Serum

166

1.21

0.29

1.1

1.0

1.09

0.45

u/ml

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

525

1.11

0.29

2.3

3.7

102.94

223.85

nmol/l

1.81

520

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

368

3552

1.04

0.28

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

182

1730

1.05

0.27

1.5

1.7

—

32.21

—

(4133840) Spirometry

150

1.20

0.26

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

481

1.10

0.26

2.4

2.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.30

0.26

1.9

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

297

2861

1.04

0.26

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.68

0.26

7.4

4.7

—

(4211845) Urine protein measurement

386

1.11

0.25

5.0

3.5

—

(3019225) pH of Specimen

821

8038

1.02

0.25

6.4

4.5

7.37

7.36

0.62

675

5767

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.25

0.25

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

713

1.08

0.25

2.8

3.1

79.94

45.36

mg/l

0.47

532

(3000963) Hemoglobin [Mass/volume] in Blood

7097

71159

0.98

0.23

53.3

29.4

130.12

133.25

g/l

51.85

7057

70206

(1617658) Protocol used for examination of sentinel lymph nodes

432

0.90

0.23

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.25

0.22

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

371

1.11

0.22

2.0

1.7

37.90

39.52

g/l

1.04

371

(3014599) Egg white IgE Ab [Units/volume] in Serum

200

1.15

0.22

1.0

1.1

0.61

2.91

u/ml

1.31

(3007461) Platelets [#/volume] in Blood

7096

71140

0.98

0.22

53.0

29.2

244.51

240.79

e9/l

4.48

7004

69431

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

7097

71149

0.98

0.22

54.7

29.7

39.36

39.78

9.00

7054

70130

(3026361) Erythrocytes [#/volume] in Blood

7097

71149

0.98

0.22

52.8

29.1

4.32

4.41

e12/l

34.74

6986

69169

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

178

0.84

0.22

1.4

1.3

1.17

mmol/l

0.07

178

(3035941) MCH [Entitic mass]

7097

71146

0.98

0.21

52.6

29.0

30.46

0.04

7054

70167

(3024731) MCV [Entitic mean volume] in Red Blood Cells

7097

71146

0.98

0.21

52.7

29.1

92.49

91.71

33.90

7053

70167

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

301.82

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

1.45

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

1655.00

—

(4038314) Semen analysis, post vasectomy

0.00

0.21

0.0

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

177

0.85

0.21

2.0

2.3

7.90

7.92

mmol/l

—

114

(3010813) Leukocytes [#/volume] in Blood

7099

71159

0.98

0.20

52.9

29.2

7.80

6.90

e9/l

79.33

6990

69177

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

189

1965

0.96

0.20

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.25

0.20

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

161

1677

0.96

0.19

5.9

3.8

28.11

30.16

mg/l

0.35

128

1193

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

241

1.12

0.19

3.7

6.3

77.95

70.76

1.29

186

(3036071) Salmonella sp Ab [Titer] in Serum

166

1.14

0.18

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

177

1706

1.04

0.18

2.1

1.7

20.23

4.72

mg/l

5.97

159

1296

(3025549) Creatine [Moles/time] in 24 hour Urine

1.17

0.17

1.6

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

176

1.14

0.17

2.2

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

271

2637

1.03

0.16

1.7

1.8

—

(3022621) pH of Urine by Test strip

602

5919

1.02

0.16

3.8

2.9

6.13

6.04

1.73

461

4216

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

662

1.06

0.15

1.3

1.2

7.19

7.82

mmol/l

1.20

561

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

192

0.89

0.14

2.0

2.5

1.78

1.20

ug/l

0.50

183

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

140

1450

0.96

0.14

2.0

1.9

193.45

200.36

pmol/l

0.38

127

1347

(3002619) Bacteria identified in Specimen by Culture

179

1.12

0.14

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

658

6490

1.01

0.13

1.5

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

138

0.87

0.13

1.4

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

284

2784

1.02

0.11

3.3

4.0

56.79

79.24

u/ml

0.95

273

2679

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.11

0.09

2.2

2.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1011

0.97

0.09

6.2

4.8

340.28

345.19

umol/l

0.12

870

(3017446) Testosterone [Moles/volume] in Serum or Plasma

626

6327

0.99

0.09

2.7

2.2

12.39

12.56

nmol/l

0.21

546

5582

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

174

1.09

0.09

2.2

2.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

136

1.10

0.08

2.1

1.8

0.33

1.40

u/ml

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

253

1.07

0.08

2.1

2.9

29.75

28.70

umol/l

0.14

190

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

361

1.05

0.08

4.2

7.0

7.70

208.52

ug/l

1.40

230

(3024869) Neuronal Ab [Presence] in Serum

164

0.91

0.08

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.86

0.07

1.0

1.1

7.83

14.24

u/l

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.05

0.07

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.87

0.07

1.1

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.03

0.07

1.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6472

64793

0.99

0.07

6.0

5.7

6.12

6.08

mmol/l

0.93

5888

58456

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

202

0.94

0.05

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

292

0.96

0.04

1.4

1.3

5.96

6.17

mmol/l

0.44

273

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

229

1.05

0.04

1.2

—

(4146454) Self-monitoring of blood glucose

976

0.98

0.04

2.6

2.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

482

0.97

0.03

1.3

36.14

31.11

u/l

0.44

398

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

108

0.93

0.03

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

292

1.03

0.02

1.3

141.13

166.83

mmol/24h

1.22

292

(40762814) Titanium [Mass/volume] in Blood

147

0.95

0.01

2.5

2.3

3.77

3.68

ug/l

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

516

0.99

0.00

1.8

1.4

0.17

0.26

nmol/l

1.92

371

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.02

0.00

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

542

1.00

0.00

2.4

1.8

144.86

112.11

ng/l

1.01

542

(3006270) Folate [Moles/volume] in Blood

665

1.01

0.00

1.1

1.2

328.13

336.60

nmol/l

0.12

518

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

25.80

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3444.14

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.4

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

-0.00

0.0

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

35.85

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

18.17

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.98

-0.00

3.2

2.3

0.72

0.65

ug/l

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

1.80

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.02

-0.00

1.4

1.1

6.34

6.26

mmol/l

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.94

-0.00

1.2

1.1

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.8

—

14.00

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.01

-0.00

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.8

—

0.27

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: J10_INTERSTITIUM – Other respiratory diseases principally affecting the interstitium

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other respiratory diseases principally affecting the interstitium

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other respiratory diseases principally affecting the interstitium (J10_INTERSTITIUM)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints